Skip Navigation
Skip to contents

Intest Res : Intestinal Research

Search
Advanced Search
IMPACT FACTOR
mobile search button mobile menu button

Articles

Page Path
HOME > Intest Res > Volume 14(2); 2016 > Article
Review Changing epidemiological trends of inflammatory bowel disease in Asia
Wee Khoon Ng1,2, Sunny H. Wong1, Siew C. Ng1
Intestinal Research 2016;14(2):111-119.
DOI: https://doi.org/10.5217/ir.2016.14.2.111
Published online: April 27, 2016

1Department of Medicine and Therapeutics, Institute of Digestive Disease, State Key Laboratory of Digestive Diseases and LKS Institute of Health Science, The Chinese University of Hong Kong, Hong Kong, China.

2Department of Gastroenterology and Hepatology, Tan Tock Seng Hospital, Singapore, Singapore.

Correspondence to Siew C. Ng, Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, China. Tel: +852-25362-3996, Fax: +852-2637-3852, siewchienng@cuhk.edu.hk
• Received: March 18, 2016   • Revised: March 18, 2016   • Accepted: March 21, 2016

© Copyright 2016. Korean Association for the Study of Intestinal Diseases. All rights reserved.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next
  • 17,131 Views
  • 264 Download
  • 241 Web of Science
  • 250 Crossref
  • 263 Scopus
Full Article

Download PDF Download PDF

  • Inflammatory bowel disease (IBD) has become more common in Asia over the past few decades. The rate of increase in prevalence of the disease varies greatly in Asia, with several countries in East Asia experiencing a more than doubled increase in IBD prevalence over the past decade. Historically, ulcerative colitis (UC) is more common than Crohn's disease (CD) in Asia. However, a reverse trend is beginning to appear in more developed countries in Asia such as Japan, Korea, and Hong Kong. While Asian IBD patients share many similarities with their Western counterparts, there are important differences with significant clinical implications. In Asia, there are more men with CD, more ileo-colonic involvement in CD, less familial aggregation, fewer extra-intestinal manifestations and worse clinical outcomes for older-onset patients with UC. These differences are likely related to the different genetic makeup and environmental exposures in different regions. Evaluation of the differences and rates in epidemiologic trends may help researchers and clinicians estimate disease burden and understand the reasons behind these differences, which may hold the key to unravel the etiology of IBD.
  • Keywords: Inflammatory bowel diseases; Colitis, ulcerative; Crohn disease; Asia; Epidemiology
Inflammatory bowel disease (IBD) includes UC and CD. It is a chronic inflammatory disease that involves the gastrointestinal tract and results from a combination of genetic susceptibility, environmental exposure, and dysregulated responses to intestinal microbiota.1 The highest occurrence of IBD is seen in developed countries in North America and Europe, affecting up to 0.5% of the general population.2 Despite its previously low incidence, Asia has been experiencing a significant increase in IBD incidence in the past two decades,34 while Europe has had a plateauing or even decreasing trend of incidence.2 This rapid increase in incidence, coupled to the considerable socioeconomic changes in Asia, has given rise to an opportunity to study the etiology of IBD.
1. Incidence
The incidences of UC and CD are highest in the West with annual rates as high as 24.3 per 100,000 and 29.3 per 100,000 persons, respectively.25 Despite IBD being much less common in Asia than in the West, it is of concern that the incidence of UC and CD are rising in parallel with rapid urbanization. The highest incidence was mainly reported in East Asia (Korea, Japan, China, Hong Kong) and South Asia (India). A large-scale population-based study of 8 Asian countries (mainland China, Hong Kong, Macau, Singapore, Malaysia, Thailand, Sri Lanka and Indonesia) in 2013 (ACCESS), has shown notable variations in IBD incidence, ranging from 0.54 to 3.44 per 100,000 persons. In this study, the highest annual incidence of IBD was seen in East Asian urbanized areas like Guangzhou (mainland China) at 3.44 per 100,000, with Hong Kong following closely behind at 3.06 per 100,000 and Macau at 2.2 per 100,000 persons. Lower rates were reported in the Southeast Asian countries. There were also notable differences in the incidence of IBD incidence within the same country. In mainland China, the IBD incidence in Guangzhou, Wuhan, Daqing, Chengdu, and Xian were 3.44, 1.96, 1.77, 0.58, and 0.54 per 100,000 persons, respectively.467 These differences have been attributed to the disparate levels of industrialization in these regions or variations in health care systems, including different access to healthcare. Higher UC and CD incidences have been reported in South Korea at 4.60 and 3.20 per 100,000 persons, respectively.
Nevertheless, not all developed countries in Asia share a similar incidence. It is noteworthy that even highly urbanized countries like Singapore and Malaysia have a much lower IBD incidence at 1.06 per 100,000 and 0.94 per 100,000 persons, respectively.4 This may be a consequence of the multi-ethnicity within these countries, with a varying genetic predisposition, lifestyle habits, and other possible unknown environmental factors. To help understand the incidence in different ethnic groups within a country, an analysis of the IBD incidence by race was conducted in Malaysia. The highest rate was seen in Indians (1.91 per 100,000 persons), followed by Chinese (0.63 per 100,000 persons), and Malays (0.35 per 100,000 persons).8 This is also in keeping with a house-to-house survey in Punjab (North India) from 1999 to 2000, which showed a much higher incidence and prevalence rate of UC in the Punjabi populations at 6.02 and 44.3 per 100,000 persons, respectively.9 The distinction in the inter-racial IBD incidence rates supports the likelihood of genetic factors, although different lifestyle and environmental factors may exist for these different ethnic groups. These are important factors to consider when reviewing incidence and prevalence rates in multi-ethnic countries.
Furthermore, rural and urban areas within Asian countries may experience different rates in IBD increases. One such example is a recent hospital-based study in Korea from an area outside of the city of Seoul, which demonstrated lower rates of complicated disease. Long-term population-based epidemiological studies covering rural as well as urban areas within Asia would help us understand the characteristics of IBD in this region and the interregional differences.10
2. Prevalence
IBD is a chronic disease that involves young patients. In addition, its rapidly increasing incidence together with the better access and delivery of healthcare is resulting in an exponential growth in the prevalence of IBD in Asia. The effect of compounding prevalence11 of IBD in Asia is crucial for future healthcare planning, as existing systems in newly industrialized countries may not be ready for the staggering increase in disease burden. From 1991 to 2005, the prevalence of UC in Japan has increased by 3.5-fold from 18.1 to 63.6 per 100,000 persons, while the prevalence of CD has increased by 3-fold from 5.9 to 21.1 per 100,000 persons.1213 The latest information available from the Japanese National IBD registry has shown that the prevalence of UC and CD has increased significantly to 121.9 and 30.1 per 100,000 persons respectively in 2013.14 This observation emphasizes the importance for healthcare systems in Asia to pre-emptively invest resources in preparation for the burgeoning IBD burden.
3. Temporal Trend
In general, UC tends to appear first in areas with emerging IBD, followed by CD at a variable interval. In North America, the incidence of UC and CD increased from 8.3 and 6.9 per 100,000 persons, respectively, in 1993,15 to 14.3 and 14.6 per 100,000, respectively, in 2004.16 A similar trend was also observed amongst Asian countries in the past few decades. Incidences for both UC and CD were rapidly rising in Asia, with CD having a steeper increment in more developed countries, resulting in a reducing UC:CD ratio over time. A large prospective population-based epidemiological study from South Korea (Korean Association for the Study of Intestinal Diseases [KASID]) showed at least a 10-fold increase in the incidence of UC and CD over two decades. The UC and CD incidence rates increased from 0.34 and 0.05 per 100,000 persons, respectively, from 1986 to 1990, to 3.08 and 1.34 per 100,000 persons from 2001 to 2005. There is also a reduction in the UC to CD ratio from 6.8 to 2.3 during the same period, demonstrating a sharper rise in CD incidence over time.17 More recent Korean data have reported that the incidence of UC and CD have further increased to 5.0 and 3.6 per 100,000 persons, respectively, in 2006. Within this same study, both the incidence of UC and CD were observed to have stabilized and perhaps are showing a slight reduction trend; the most recent incidence for UC and CD in 2012 was 4.2 and 3.1 per 100,000 persons, respectively.18
Table 1 summarises the available incidence and prevalence rates of IBD in various Asian countries.
There is varying genetic predisposition to IBD in different regions. Major nucleotide oligomerisation domain (NOD2) variants in Caucasians have not been identified in many of the Asian ethnicities (Han Chinese, Japanese, Korean, Indian and Malaysians).22 However, novel NOD2 mutations associated with CD have been reported in Malaysians (JW1 mutation) and Han Chinese and Indians (P268S mutation).23 Amongst Asian populations, tumor necrosis factor superfamily 15 (TNFSF15) polymorphisms are associated with CD, while the TNF α-308 polymorphism is associated with UC. A recent large-scale trans-ethnic study has also demonstrated the significant genetic heterogeneity between East Asian, Indian, and Iranian populations in Asia.24 Identification of novel genes and genetic variants in Asian patients will help us comprehend the genotype to phenotype contribution to IBD's disease course and also explain the differing genetic predisposition between ethnicities.
While genetic factors are important in the pathogenesis of IBD, genetic predilection alone is insufficient to result in disease manifestation. Studies of monozygotic twins report a concordance rate for CD ranging from 20% to 50% and a much lower rate for UC,252627 advocating for the presence of other important environmental factors in the development of IBD.
Environmental factors play an integral role in IBD pathogenesis. A prospective study evaluating South Asian immigrants to Leicester, United Kingdom (UK), has shown that UK born children of South Asian descent had a comparable risk of developing UC as the local population,28 despite having lower rates of UC in their native countries. Such studies have been pivotal in substantiating the role of environmental factors in the development of IBD.2930 A more recent retrospective study of a population-based cohort of IBD patients in Ontario, Canada, has reported the association of younger age of immigration to Canada and an increased risk of IBD (14% increased risk per younger decade of life at immigration). Canadian-born children of immigrants from some regions (Middle East/North Africa, South Asia, Sub-Saharan Africa) assumed an equally high IBD incidence as children of non-immigrants, supporting the importance of early-life environmental exposures in the development of IBD.3132
1. Smoking
Western studies reported smoking as a consistent factor associated with IBD, increasing the risk of CD but reducing the risk of UC.33343536 Furthermore, actively smoking CD patients undergo a worse disease trajectory, with a higher risk of relapse after remission. On the contrary, UC patients are more likely to have a disease flare after smoking cessation.37 It appears that smoking does not have such a marked impact on Asian CD patients. At a population level, Western countries like Canada and Sweden with a high CD incidence have a lower prevalence of smoking in the adult population (<30%). In comparison to Asian countries with a much higher smoking prevalence (>65% of men), a much lower CD incidence has been reported. This observation suggests that although smoking is an important risk factor for CD, it could only influence the disease course but may not be sufficient to affect population trends in IBD.38
2. Appendectomy
Asian studies from Japan39 and China40 have shown that appendectomy is associated with a decreased risk of developing UC, similar to the Western data.41 The notion of appendicitis rather than appendectomy having a protective effect against UC in the Western population,4243 does not have any corroborative data in Asia. Currently, there is no convincing evidence to associate appendectomy to the development of CD.
3. Diet
Several studies from the West have reported that increased consumption of linoleic acid44 and animal protein45 are associated with an increased risk of IBD, especially for UC in healthy women. Increased intake of fats, fatty acids, sugar, and meat are correlated with an increased risk of UC relapse.46 High sugar consumption has also been reported to increase the predisposition to develop CD.47 On the contrary, increased fiber, fruit, and vegetable intake seem to reduce the risk of IBD development.48 Studies from Japan have reported similar findings, showing that increased intake of sweets, fats, fatty acids, meat, and oil correlate with the increased risk of developing IBD.4950 A recent case control population-based study involving 9 different Asia Pacific countries (ACCESS) has reported that more than 12 months of breast feeding has a marked protective effect on the development of both UC and CD. Consumption of tea or coffee has also been noted to have a protective effect51 against IBD.
4. Antibiotics Usage
Several observational studies from the West have shown an association between antibiotic usage and the subsequent diagnosis of IBD, although the causality has not been proven.525354 In contrast, the only available Asian study has reported a protective effect of childhood antibiotics against the development of UC and CD. This paradoxical effect might be a consequence of childhood antibiotics usage being a surrogate for gastrointestinal infections, which in turn result in the induction of tolerance.51
Many of the clinical manifestations of IBD in Asia share similar characteristics to patients in the West. Nonetheless, there are several notable differences that are relevant to physicians.
1. Sex
There seems to be an overall female preponderance for IBD in the Western literature.5556 In Canada, the women to men incidence rate ratio can be as high as 1.53 for CD and 1.21 for UC in certain provinces.55 However, what is more consistently observed is the female preponderance for CD but an equal or slight female preponderance in UC. On the contrary, Asian data seem to support a male preponderance for CD, but an equal or slight male preponderance for UC. The men to women ratio in Asia for CD was as high as 2.83.1720215758 Thus far, there has not been a proven cause for such a phenomenon. Possibilities would include a different genetic susceptibility and men having greater chances to seek education or job opportunities in industrialized areas at a younger age, which increases their early-life exposure to potential environmental risk factors. Continued monitoring of the epidemiological evolution in Asia will be important to detect any reversal of the sex ratio over time, to parallel that of Western data.
2. Age
Multiple Western studies have reported a bimodal distribution in the age at diagnosis of IBD patients, with a younger peak age at 20 to 30 years for CD, 30 to 40 years for UC, and a lower second older peak at 60 to 70 years for both diseases.59 This bimodal distribution by age has not been consistently reported in Asia, with several newer Asian studies demonstrating only the presence of a first peak at a comparable younger age and a much less prominent second peak.917206061
3. Disease Presentation and Course
Clinical presentations for UC are comparable between Asian and Western populations, with some Chinese data reporting a milder disease course and less fulminant colitis.6061 More differences are noted between Asian CD patients and their Western counterparts. Ileal, colonic, and ileocolonic involvement are usually found in equal proportions in the Western CD population. Data from East Asia has observed that ileocolonic disease is the most common CD phenotype, with 71.0% in Guangdong (China),62 66.7% in South Korea,17 65.8% in Japan,63 and 50.5% in Hong Kong.64 More heterogeneity in CD disease involvement is noted in South and West Asia.6165 Of significance, perianal disease is commonly detected in East Asian patients, involving 58.8% of CD patients in Guangdong (China),62 43.1% in Korea,66 and 30.3% in Hong Kong.64 This is higher than the Caucasian CD data, with reported rates in CD patients with perianal disease up to 29.6% in a multi-center American and European study,67 26.6% in New Zealand,68 and 25.1% in France.69 It has also been reported that colectomy rates for UC and CD are lower in Asia (1% at 1 year), with the exact reason yet to be determined. Postulations included a milder UC course and a higher threshold to perform colectomy in Asia.6570
4. Family History
Familial aggregation among IBD patients is commonly reported in the Western population, and is more frequently noted in CD than UC.71727374 A systematic review has noted that 0% to 3.4% of Asian IBD patients have familial aggregation, which is much lower than the reported rates of 10% to 25% in Western countries.75
5. Extra-intestinal Manifestations (EIM)
There is a significant variation in the prevalence of EIM in Asia, with the highest reported prevalence in India, involving around one-third of the IBD patients.7576 In contrast, the reported prevalence of EIM in East Asia is significantly lower at 6% to 14%,65 compared to 21% to 41% in the West.777879
6. Colorectal Cancer (CRC)
Available Asian data indicates a lower overall prevalence rate of 2.2% of UC related CRC406480818283 compared to the 3% to 5% in the West.8485 However, it is important to note that the available Asian studies have shorter durations of follow-up. Other contributory factors for lower reported CRC rates in Asia include the shorter UC history in the region and also relatively lower disease prevalence. It is probable that the prevalence of UC-related CRC will increase in parallel with the increasing disease prevalence and duration of disease in Asia.
7. Older-onset IBD
Older-onset IBD refers to patients diagnosed with IBD at an age above 60 years. Studies from Western countries have generally reported a less aggressive course of IBD,86 especially for UC.868788 In contrast, Asian older-onset UC patients tend to have a similar,89 if not worse, outcome than the younger-onset UC patients.9091 A Hong Kong retrospective population-based study has reported that older-onset UC is associated with a higher risk of suffering from opportunistic infections like cytomegalovirus and Clostridium difficile , higher rates of hospitalization for UC flares, CRC, all-cause mortality, and UC-related mortality compared to younger-onset patients.90 This disparate clinical course is clinically important, because it accentuates that the available Western data do not necessarily translate to similar trends in Asia. This finding advocates for ongoing Asian IBD epidemiological studies to detect such dissimilarities.
A recent systematic review and meta-analysis of available studies worldwide has observed that older-onset CD patients are more likely to have isolated colonic involvement, which are predominantly inflammatory in nature and are infrequently associated with perianal disease. Older-onset UC is more similar to younger-onset UC, with a slightly higher likelihood of left sided colitis but not pancolitis. Although immunomodulators and biologics are less commonly used in older-onset IBD patients, this was not supported by lower surgical rates. On the contrary, older-onset UC patients have higher rates of surgery, suggesting that the disease course for olderonset IBD is not more benign than younger-onset disease.92
An exponential increase in the prevalence of IBD within Asia is of concern and it is imperative that Asian healthcare systems are prepared for this. Despite this being the same condition afflicting both Western and Asian populations, there are several significant variations in its phenotype, possibly as a result of the differences in genetic composition and environmental influences. Physicians should be cognizant of these differences and be prepared to individualize management for their patients. Evaluating the differences between Asian and Western IBD data will help us better understand the etiology of IBD. Well-conducted epidemiological studies in more areas with different rates of urbanization within Asia are essential for us to achieve this goal.

Financial support: Dr. Sunny H. Wong is supported by the Croucher Foundation, Hong Kong.

Conflict of interest: None.

  • 1. Danese S, Fiocchi C. Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol 2006;12:4807–4812.PMID: 16937461.ArticlePubMedPMC
  • 2. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46–54.e42.PMID: 22001864.ArticlePubMed
  • 3. Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008;103:3167–3182.PMID: 19086963.ArticlePubMed
  • 4. Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology 2013;145:158–165.e2.PMID: 23583432.ArticlePubMed
  • 5. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011;140:1785–1794.PMID: 21530745.ArticlePubMed
  • 6. Zhao J, Ng SC, Lei Y, et al. First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of "western" disease. Inflamm Bowel Dis 2013;19:1839–1845.PMID: 23669403.ArticlePubMed
  • 7. Yang H, Li Y, Wu W, et al. The incidence of inflammatory bowel disease in Northern China: a prospective population-based study. PLoS One 2014;9:e101296PMID: 10.1371/journal.pone.0101296. PMID: 25029440.ArticlePubMedPMC
  • 8. Hilmi I, Jaya F, Chua A, Heng WC, Singh H, Goh KL. A first study on the incidence and prevalence of IBD in Malaysia–results from the Kinta Valley IBD Epidemiology Study. J Crohns Colitis 2015;9:404–409.PMID: 25744112.ArticlePubMedPDF
  • 9. Sood A, Midha V, Sood N, Bhatia AS, Avasthi G. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 2003;52:1587–1590.PMID: 14570727.ArticlePubMedPMC
  • 10. Lee EJ, Kim TO, Song GA, et al. Clinical features of Crohn's disease in Korean patients residing in Busan and Gyeongnam. Intest Res 2016;14:30–36.PMID: 26884732.ArticlePubMedPMC
  • 11. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol 2015;12:720–727.PMID: 26323879.ArticlePubMedPDF
  • 12. Morita N, Toki S, Hirohashi T, et al. Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J Gastroenterol 1995;30(Suppl 8): 1–4.PMID: 8563866.Article
  • 13. Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn's disease in Japan. J Gastroenterol 2009;44:659–665.PMID: 19424654.ArticlePubMed
  • 14. Japanese Ministry of Health, Labour and Welfare. Handbook of Health and Welfare Statistics 2014 Contents. Table 2-22 Number of persons with specific (intractable) disease healthcare certificate by disease and sex http://www.mhlw.go.jp/english/database/db-hh/2-1.html.
  • 15. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504–1517.PMID: 15168363.ArticlePubMed
  • 16. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007;5:1424–1429.PMID: 17904915.ArticlePubMed
  • 17. Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis 2008;14:542–549.PMID: 17941073.ArticlePubMed
  • 18. Kim HJ, Hann HJ, Hong SN, et al. Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012: a nationwide population-based study. Inflamm Bowel Dis 2015;21:623–630.PMID: 25647154.ArticlePubMed
  • 19. Yoshida Y, Murata Y. Inflammatory bowel disease in Japan: studies of epidemiology and etiopathogenesis. Med Clin North Am 1990;74:67–90.PMID: 2404182.ArticlePubMed
  • 20. Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm Bowel Dis 2004;10:646–651.PMID: 15472528.ArticlePubMed
  • 21. Kuo CJ, Yu KH, See LC, et al. The trend of inflammatory bowel diseases in Taiwan: a population-based study. Dig Dis Sci 2015;60:2454–2462.PMID: 25837597.ArticlePubMed
  • 22. Ng SC, Tsoi KK, Kamm MA, et al. Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflamm Bowel Dis 2012;18:1164–1176.PMID: 21887729.ArticlePubMed
  • 23. Chua KH, Hilmi I, Ng CC, et al. Identification of NOD2/CARD15 mutations in Malaysian patients with Crohn's disease. J Dig Dis 2009;10:124–130.PMID: 19426395.ArticlePubMed
  • 24. Liu JZ, van Sommeren S, Huang H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 2015;47:979–986.PMID: 26192919.ArticlePubMedPMCPDF
  • 25. Halfvarson J, Jess T, Magnuson A, et al. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis 2006;12:925–933.PMID: 17012962.ArticlePubMed
  • 26. Orholm M, Binder V, Sørensen TI, Rasmussen LP, Kyvik KO. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol 2000;35:1075–1081.PMID: 11099061.ArticlePubMed
  • 27. Thompson NP, Driscoll R, Pounder RE, Wakefield AJ. Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ 1996;312:95–96.PMID: 8555939.ArticlePubMedPMC
  • 28. Carr I, Mayberry JF. The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and first- and second- generation South Asians in Leicester (1991-1994). Am J Gastroenterol 1999;94:2918–2922.PMID: 10520845.ArticlePubMed
  • 29. Jayanthi V, Probert CS, Pinder D, Wicks AC, Mayberry JF. Epidemiology of Crohn's disease in Indian migrants and the indigenous population in Leicestershire. Q J Med 1992;82:125–138.PMID: 1620813.PubMed
  • 30. Probert CS, Jayanthi V, Pinder D, Wicks AC, Mayberry JF. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 1992;33:687–693.PMID: 1307684.ArticlePubMedPMC
  • 31. Benchimol EI, Mack DR, Guttmann A, et al. Inflammatory bowel disease in immigrants to Canada and their children: a population-based cohort study. Am J Gastroenterol 2015;110:553–563.PMID: 25756238.ArticlePubMedPDF
  • 32. Benchimol EI, Manuel DG, To T, et al. Asthma, type 1 and type 2 diabetes mellitus, and inflammatory bowel disease amongst South Asian immigrants to Canada and their children: a population-based cohort study. PLoS One 2015;10:e0123599PMID: 10.1371/journal.pone.0123599. PMID: 25849480.ArticlePubMedPMC
  • 33. van der Heide F, Dijkstra A, Weersma RK, et al. Effects of active and passive smoking on disease course of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2009;15:1199–1207.PMID: 19170191.ArticlePubMed
  • 34. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989;34:1841–1854.PMID: 2598752.ArticlePubMedPDF
  • 35. Boyko EJ, Koepsell TD, Perera DR, Inui TS. Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med 1987;316:707–710.PMID: 3821808.ArticlePubMed
  • 36. Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990;98:1123–1128.PMID: 2323505.ArticlePubMed
  • 37. Cosnes J, Beaugerie L, Carbonnel F, Gendre JP. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 2001;120:1093–1099.PMID: 11266373.ArticlePubMed
  • 38. Prideaux L, Kamm MA, De Cruz P, et al. Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne. J Gastroenterol Hepatol 2012;27:919–927.PMID: 22098103.ArticlePubMed
  • 39. Naganuma M, Iizuka B, Torii A, et al. Appendectomy protects against the development of ulcerative colitis and reduces its recurrence: results of a multicenter case-controlled study in Japan. Am J Gastroenterol 2001;96:1123–1126.PMID: 11316158.ArticlePubMed
  • 40. Jiang L, Xia B, Li J, et al. Risk factors for ulcerative colitis in a Chinese population: an age-matched and sex-matched case-control study. J Clin Gastroenterol 2007;41:280–284.PMID: 17426467.ArticlePubMed
  • 41. Koutroubakis IE, Vlachonikolis IG, Kouroumalis EA. Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review. Inflamm Bowel Dis 2002;8:277–286.PMID: 12131612.ArticlePubMed
  • 42. Frisch M, Pedersen BV, Andersson RE. Appendicitis, mesenteric lymphadenitis, and subsequent risk of ulcerative colitis: cohort studies in Sweden and Denmark. BMJ 2009;338:b716PMID: 10.1136/bmj.b716. PMID: 19273506.ArticlePubMedPMC
  • 43. Beaugerie L, Sokol H. Appendicitis, not appendectomy, is protective against ulcerative colitis, both in the general population and first-degree relatives of patients with IBD. Inflamm Bowel Dis 2010;16:356–357.PMID: 19685454.ArticlePubMed
  • 44. IBD in EPIC Study Investigators. Tjonneland A, Overvad K, et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut 2009;58:1606–1611.PMID: 19628674.ArticlePubMed
  • 45. Jantchou P, Morois S, Clavel-Chapelon F, Boutron-Ruault MC, Carbonnel F. Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study. Am J Gastroenterol 2010;105:2195–2201.PMID: 20461067.ArticlePubMedPDF
  • 46. Jowett SL, Seal CJ, Pearce MS, et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut 2004;53:1479–1484.PMID: 15361498.ArticlePubMedPMC
  • 47. Riordan AM, Ruxton CH, Hunter JO. A review of associations between Crohn's disease and consumption of sugars. Eur J Clin Nutr 1998;52:229–238.PMID: 9578334.ArticlePubMedPDF
  • 48. Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 2011;106:563–573.PMID: 21468064.ArticlePubMedPDF
  • 49. Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 1996;63:741–745.PMID: 8615358.ArticlePubMedPDF
  • 50. Sakamoto N, Kono S, Wakai K, et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis 2005;11:154–163.PMID: 15677909.ArticlePubMed
  • 51. Ng SC, Tang W, Leong RW, et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut 2015;64:1063–1071.PMID: 25217388.ArticlePubMed
  • 52. Virta L, Auvinen A, Helenius H, Huovinen P, Kolho KL. Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease–a nationwide, register-based finnish case-control study. Am J Epidemiol 2012;175:775–784.PMID: 22366379.ArticlePubMedPDF
  • 53. Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis. Am J Gastroenterol 2011;106:2133–2142.PMID: 21912437.ArticlePubMedPDF
  • 54. Hviid A, Svanström H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 2011;60:49–54.PMID: 20966024.ArticlePubMed
  • 55. Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006;101:1559–1568.PMID: 16863561.ArticlePubMed
  • 56. Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006;101:1274–1282.PMID: 16771949.ArticlePubMed
  • 57. Yao T, Matsui T, Hiwatashi N. Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum 2000;43(10 Suppl): S85–S93.PMID: 11052483.ArticlePubMed
  • 58. Jiang L, Xia B, Li J, et al. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis 2006;12:212–217.PMID: 16534423.ArticlePubMed
  • 59. Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 2002;31:1–20.PMID: 12122726.ArticlePubMed
  • 60. Jiang XL, Cui HF. An analysis of 10218 ulcerative colitis cases in China. World J Gastroenterol 2002;8:158–161.PMID: 11833094.ArticlePubMedPMC
  • 61. Wang YF, Zhang H, Ouyang Q. Clinical manifestations of inflammatory bowel disease: East and West differences. J Dig Dis 2007;8:121–127.PMID: 17650222.ArticlePubMed
  • 62. Zeng Z, Zhu Z, Yang Y, et al. Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: a prospective population-based study. J Gastroenterol Hepatol 2013;28:1148–1153.PMID: 23432198.ArticlePubMed
  • 63. Oriuchi T, Hiwatashi N, Kinouchi Y, et al. Clinical course and longterm prognosis of Japanese patients with Crohn's disease: predictive factors, rates of operation, and mortality. J Gastroenterol 2003;38:942–953.PMID: 14614601.ArticlePubMed
  • 64. Chow DK, Leong RW, Lai LH, et al. Changes in Crohn's disease phenotype over time in the Chinese population: validation of the Montreal classification system. Inflamm Bowel Dis 2008;14:536–541.PMID: 18058793.ArticlePubMed
  • 65. Ng SC. Epidemiology of inflammatory bowel disease: focus on Asia. Best Pract Res Clin Gastroenterol 2014;28:363–372.PMID: 24913377.ArticlePubMed
  • 66. Park SH, Yang SK, Park SK, et al. Long-term prognosis of Crohn's disease and its temporal change between 1981 and 2012: a hospital-based cohort study from Korea. Inflamm Bowel Dis 2014;20:488–494.PMID: 24412992.ArticlePubMed
  • 67. Sachar DB, Bodian CA, Goldstein ES, et al. Is perianal Crohn's disease associated with intestinal fistulization? Am J Gastroenterol 2005;100:1547–1549.PMID: 15984979.ArticlePubMed
  • 68. Eglinton TW, Barclay ML, Gearry RB, Frizelle FA. The spectrum of perianal Crohn's disease in a population-based cohort. Dis Colon Rectum 2012;55:773–777.PMID: 22706129.ArticlePubMed
  • 69. Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn's disease. Gastroenterology 2006;130:650–656.PMID: 16530505.ArticlePubMed
  • 70. Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol 2012;27:1266–1280.PMID: 22497584.ArticlePubMed
  • 71. Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen TI, Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991;324:84–88.PMID: 1984188.ArticlePubMed
  • 72. Peeters M, Nevens H, Baert F, et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 1996;111:597–603.PMID: 8780562.ArticlePubMed
  • 73. Yang H, McElree C, Roth MP, Shanahan F, Targan SR, Rotter JI. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut 1993;34:517–524.PMID: 8491401.ArticlePubMedPMC
  • 74. Roth MP, Petersen GM, McElree C, Vadheim CM, Panish JF, Rotter JI. Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology 1989;96:1016–1020.PMID: 2925048.ArticlePubMed
  • 75. Kochhar R, Mehta SK, Nagi B, Bhatia V, Goenka MK, Malik AK. Extraintestinal manifestations of idiopathic ulcerative colitis. Indian J Gastroenterol 1991;10:88–89.PMID: 1916969.PubMed
  • 76. Bandyopadhyay D, Bandyopadhyay S, Ghosh P, et al. Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients. Indian J Gastroenterol 2015;34:387–394.PMID: 26614005.ArticlePubMed
  • 77. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976;55:401–412.PMID: 957999.ArticlePubMed
  • 78. Monsén U, Sorstad J, Hellers G, Johansson C. Extracolonic diagnoses in ulcerative colitis: an epidemiological study. Am J Gastroenterol 1990;85:711–716.PMID: 2353691.PubMed
  • 79. Rankin GB, Watts HD, Melnyk CS, Kelley ML Jr. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 1979;77:914–920.PMID: 467943.ArticlePubMed
  • 80. Ling KL, Ooi CJ, Luman W, Cheong WK, Choen FS, Ng HS. Clinical characteristics of ulcerative colitis in Singapore, a multiracial city-state. J Clin Gastroenterol 2002;35:144–148.PMID: 12172359.ArticlePubMed
  • 81. Fujimoto T, Kato J, Nasu J, et al. Change of clinical characteristics of ulcerative colitis in Japan: analysis of 844 hospital-based patients from 1981 to 2000. Eur J Gastroenterol Hepatol 2007;19:229–235.PMID: 17301650.ArticlePubMed
  • 82. Kim BJ, Yang SK, Kim JS, et al. Trends of ulcerative colitis-associated colorectal cancer in Korea: A KASID study. J Gastroenterol Hepatol 2009;24:667–671.PMID: 19378391.ArticlePubMed
  • 83. Fujita T, Ando T, Watanabe O, et al. Clinicopathological study of colorectal cancer occurring in patients with ulcerative colitis: results from a single hospital in Japan. Hepatogastroenterology 2010;57:487–492.PMID: 20698214.PubMed
  • 84. Dobbins WO 3rd. Dysplasia and malignancy in inflammatory bowel disease. Annu Rev Med 1984;35:33–48.PMID: 6372661.ArticlePubMed
  • 85. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526–535.PMID: 11247898.ArticlePubMedPMC
  • 86. Charpentier C, Salleron J, Savoye G, et al. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut 2014;63:423–432.PMID: 23408350.ArticlePubMed
  • 87. Riegler G, Tartaglione MT, Carratú R, et al. Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis: a study by GISC (Italian Colon-Rectum Study Group). Dig Dis Sci 2000;45:462–465.PMID: 10749318.ArticlePubMed
  • 88. Triantafillidis JK, Emmanouilidis A, Pomonis E, et al. Ulcerative colitis in the elderly: clinical patterns and outcome in 51 Greek patients. J Gastroenterol 2001;36:312–316.PMID: 11388393.ArticlePubMed
  • 89. Lee JH, Cheon JH, Moon CM, et al. Do patients with ulcerative colitis diagnosed at a young age have more severe disease activity than patients diagnosed when older? Digestion 2010;81:237–243.PMID: 20110709.ArticlePubMed
  • 90. Shi HY, Chan FK, Leung WK, et al. Natural history of elderly-onset ulcerative colitis: results from a territory-wide inflammatory bowel disease registry. J Crohns Colitis 2016;10:176–185.PMID: 26512132.ArticlePubMedPDF
  • 91. Matsumoto S, Miyatani H, Yoshida Y. Ulcerative colitis: comparison between elderly and young adult patients and between elderly patients with late-onset and long-standing disease. Dig Dis Sci 2013;58:1306–1312.PMID: 23306844.ArticlePubMed
  • 92. Ananthakrishnan AN, Shi HY, Tang W, et al. Systematic review and meta-analysis: phenotype and clinical outcomes of older-onset inflammatory bowel disease. J Crohns Colitis [published online ahead of print February 29, 2016]. PMID: 10.1093/ecco-jcc/jjw054.ArticlePDF
Table 1

Incidence and Prevalence Rates of IBD in Various Asian Countries

ir-14-111-i001.jpg
Country Period Incidence Rate
(per 100,000 persons)		 UC/CD Prevalence Rate
(per 100,000 persons)
UC CD UC CD
Korea 1986−199017 0.34a 0.05a 6.8 - -
1991−199517 0.87a 0.22a 3.9 - -
1996−200017 1.74a 0.52a 3.3 7.60 -
2001−200517 3.08a 1.34a 2.3 30.90 11.20
2006−201218 4.60 3.20 1.4 - -
Japan 196519 0.08 0.01 8.0 5.50 0.88
199112 1.95 0.51 3.8 18.10 5.90
200513 - - - 63.60b 21.10b
201314 - - - 121.90 30.10
Mainland China (Guangzhou) 2011−20124 2.22 1.22 1.8 - -
Mainland China (Wuhan) 2010−20116 1.59 0.56 2.8 - -
Mainland China (Daqing) 2012−20137 1.64 0.13 12.6 - -
Mainland China (Chengdu) 2011−20124 0.43 0.14 3.0 - -
Mainland China (Xian) 2011−20124 0.42 0.07 6.0 - -
Hong Kong 1990−199220 0.80 0.40 2.0 - -
1999−200120 1.20 1.00 1.2 - -
2011−20124 1.66 1.31 1.2 - -
Macau 2011−20124 1.00 0.60 1.7 - -
Sri Lanka 2011−20124 0.95 0.59 1.6 - -
Taiwan 2000−201021 0.84 0.21 3.9 - -
Singapore 2011−20124 0.61 0.40 1.5 - -
Malaysia 2011−20134,8 0.59 0.24 2.5 6.67 2.17
Indonesia 2011−20124 0.55 0.33 1.7 - -
Thailand (Chiangmai) 2011−20124 0.36 0.30 1.2 - -
Thailand (Bangkok) 2011−20124 0.35 0.28 1.3 - -
India (Punjab) 1999−20009 6.02 - - 44.30 -

aAge and sex-standardized rates.

bAge standardized rate.

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Behçet’s disease: incidence, prevalence, and real-word data on the use of biologic agents in Japan
      Tadakazu Hisamatsu, Makoto Naganuma, Philippe Pinton, Mitsuhiro Takeno
      Journal of Gastroenterology.2025; 60(3): 294.     CrossRef
    • Management of Anal Fistula with Crohn's Disease
      Shota Takano, Yasushi Nakamura, Kohei Tamaoka, Takafumi Yoshimoto, Yasue Irei, Yoriyuki Tsuji
      Journal of the Anus, Rectum and Colon.2025; 9(1): 10.     CrossRef
    • Key Themes in the Care of Inflammatory Bowel Diseases Among Immigrant Populations: A Systematic Review
      Michael Youssef, Parul Tandon, Tyrel Jones, Varun Srikanth, Laura Targownik
      Digestive Diseases and Sciences.2025; 70(3): 1016.     CrossRef
    • The Importance of Post-Inflammatory Polyps (PIPs) in Colorectal Cancer Surveillance in Inflammatory Bowel Diseases
      Ivanna Candel, Panu Wetwittayakhlang, Talat Bessissow, Peter L. Lakatos
      Journal of Clinical Medicine.2025; 14(2): 333.     CrossRef
    • Epidemiology, pathogenesis, diagnosis, and treatment of inflammatory bowel disease: Insights from the past two years
      Jian Wan, Jiaming Zhou, Zhuo Wang, Dan Liu, Hao Zhang, Shengmao Xie, Kaichun Wu
      Chinese Medical Journal.2025; 138(7): 763.     CrossRef
    • Evaluation of the mechanism of action of Aegle marmelos in a murine model of 3% dextran sulphate sodium induced acute colitis
      Alok Nachane, Sandhya K. Kamat, Manoj Radhakrishnan, Gita Nataraj, Sunil S. Kuyare
      International Journal of Basic & Clinical Pharmacology.2025; 14(2): 275.     CrossRef
    • Current and forecasted 10-year prevalence and incidence of inflammatory bowel disease in Hong Kong, Japan, and the United States
      Yin Zhang, Hsingwen Chung, Qi-Wen Fang, You-Ran Xu, Yong-Jing Zhang, Ko Nakajo, Ian Chi-Kei Wong, Wai-Keung Leung, Hong Qiu, Xue Li
      World Journal of Gastroenterology.2025;[Epub]     CrossRef
    • The prevalence, pathophysiology, and treatment of fecal incontinence in patients with Crohn’s disease: a systematic review and meta-analysis
      Yuting Shi, Yujia Zhu, Yixin Lan, Li Xu
      Frontiers in Medicine.2025;[Epub]     CrossRef
    • The global burden of inflammatory bowel disease: from 2025 to 2045
      Gilaad G. Kaplan
      Nature Reviews Gastroenterology & Hepatology.2025; 22(10): 708.     CrossRef
    • Global Inflammatory Bowel Disease: Opportunities and Challenges for a New Era
      Ignacio Catalan‐Serra, Shaji Sebastian
      United European Gastroenterology Journal.2025; 13(8): 1410.     CrossRef
    • Crohn’s disease in coastal China: epidemiological profile and determinants of diagnostic delay in the Yancheng cohort
      Shengnan Jin, Maozhen Zhang, Zixuan Zhou, Yanping Hao, Lin Wang, Su Xu
      Frontiers in Physiology.2025;[Epub]     CrossRef
    • Nationwide estimates of patient numbers and prevalence rates of ulcerative colitis and Crohn’s disease in Japan in 2023
      Anna Tsutsui, Yoshitaka Murakami, Yuji Nishiwaki, Keiko Asakura, Satoko Ohfuji, Wakaba Fukushima, Katsuyoshi Matsuoka, Tadakazu Hisamatsu
      Journal of Gastroenterology.2025; 60(12): 1513.     CrossRef
    • Effectiveness and safety of upadacitinib for inflammatory bowel disease: A systematic review and meta-analysis of RCT and real-world observational studies
      Dian-yu Zheng, Yi-nuo Wang, Yu-Hong Huang, Min Jiang, Cong Dai
      International Immunopharmacology.2024; 126: 111229.     CrossRef
    • Scoring Indices for Perianal Fistulising Crohn’s Disease: A Systematic Review
      Sudheer K Vuyyuru, Virginia Solitano, Siddharth Singh, Jurij Hanzel, John K Macdonald, Silvio Danese, Laurent Peyrin Biroulet, Christopher Ma, Vipul Jairath
      Journal of Crohn's and Colitis.2024; 18(6): 836.     CrossRef
    • Efficacy and safety of moxibustion for ulcerative colitis: protocol for a systematic review and meta-analysis
      Yanzhen Li, Wen Zhou, Wenxiao Chen, Bailing Deng, Jianyu You
      BMJ Open.2024; 14(3): e078878.     CrossRef
    • Trends in the prevalence and incidence of Crohn’s disease in Japan and the United States
      Ko Nakajo, Michiyo Yamazaki, Hsingwen Chung, Youran Xu, Hong Qiu
      International Journal of Colorectal Disease.2024;[Epub]     CrossRef
    • Rising Incidence of Inflammatory Bowel Disease in the Asian Subcontinent—An Exploration of Causative Factors
      Priyansh Bhayani, Kartik Natarajan, Nayantara Coelho-Prabhu
      Gastrointestinal Disorders.2024; 6(2): 549.     CrossRef
    • Safety and Effectiveness of Ustekinumab for Crohn’s Disease With Perianal Manifestations: Ad hoc Analysis Data From 1-Year Post-Marketing Surveillance Study in Japan
      Katsumasa Nagano, Hiroaki Tsuchiya, Teita Asano, Hiroshi Yamazaki, Sonoko Tominaga, Takayuki Matsumoto
      Crohn's & Colitis 360.2024;[Epub]     CrossRef
    • Osteopontin regulation of MerTK+ macrophages promotes Crohn’s disease intestinal fibrosis
      Juanhan Liu, Wenbin Gong, Peizhao Liu, Yangguang Li, Haiyang Jiang, Cunxia Wu, Xiuwen Wu, Yun Zhao, Jianan Ren
      iScience.2024; 27(7): 110226.     CrossRef
    • A Continuous Registry of Medical Record, Patient Input, and Epidemiological Data of Patients With Ulcerative Colitis: a Multicentre, Prospective, Observational Clinical Registry Study in Japan
      Katsuyoshi Matsuoka, Shuji Hibiya, Katsuyoshi Ando, Yuji Tani, Takehiro Torisu, Haruei Ogino, Takanori Yamashita, Akira Andoh, Yoshihisa Sugimoto, Takayuki Matsumoto, Yusuke Iwanaga, Takashi Suda, Taku Kobayashi
      Annals of Clinical Epidemiology.2024; 6(3): 65.     CrossRef
    • Temporal Trends of Inflammatory Bowel Diseases in Taiwan from 2016 to 2020: A Population-Based Study
      Chia-Jung Kuo, Cheng-Yu Lin, Puo-Hsien Le, Yao-Wei Kuo, Chen-Ming Hsu, Ming-Wei Lai, Wey-Ran Lin, Ming-Ling Chang, Ming-Yao Su, Cheng-Tang Chiu, Chee-Jen Chang
      Digestive Diseases and Sciences.2024; 69(9): 3172.     CrossRef
    • Differences of clinical phenotype between familial and sporadic Crohn’s disease in East China
      Siyuan Dong, Xiaoxia Xiang, Yu Zhang, Rongbei Liu, Lingna Ye, Qian Cao
      International Journal of Colorectal Disease.2024;[Epub]     CrossRef
    • Predicting novel biomarkers for early diagnosis and dynamic severity monitoring of human ulcerative colitis
      Yu Chen, Li Chen, Sheng Huang, Li Yang, Li Wang, Feiyun Yang, Jinxiu Huang, Xiuliang Ding
      Frontiers in Genetics.2024;[Epub]     CrossRef
    • Concordance of phenotypic characteristics among patients with familial Crohn's disease in China
      Xiao Xia Deng, Min Zhi Lin, Xiang Gao, Xin Yu Liu, Yan Hui Wu, Kang Chao, Jian Tang
      Journal of Digestive Diseases.2024; 25(7): 444.     CrossRef
    • Effects of a Pre-Conception Care Program in Women with Inflammatory Bowel Disease: A Mixed-Methods Study Including a Randomized Controlled Trial
      Young Jin Lee, Hae Won Kim, Yeon Hee Kim, Suk-Kyun Yang, Ji-Yeon Kim
      Journal of Korean Academy of Nursing.2024; 54(3): 386.     CrossRef
    • Ulcerative colitis: molecular insights and intervention therapy
      Yuqing Liang, Yang Li, Chehao Lee, Ziwei Yu, Chongli Chen, Chao Liang
      Molecular Biomedicine.2024;[Epub]     CrossRef
    • Perianal fistulizing lesions of Crohn’s disease are associated with long-term behavior and its transition: a Chinese cohort study
      Wei Zhan, Xiaoyin Bai, Hong Yang, Jiaming Qian
      Intestinal Research.2024; 22(4): 484.     CrossRef
    • The Effects of Mannyeon-hwan on Acetic Acid-induced Ulcerative Colitis in Rats
      Won-ho Kong, Bum-hoi Kim, Won-ill Kim
      The Journal of Internal Korean Medicine.2024; 45(4): 681.     CrossRef
    • Unlocking the Power of Physical Activity in Inflammatory Bowel Disease: A Comprehensive Review
      Jiajia Chen, Shaopeng Sun, Andrew S. Day
      Gastroenterology Research and Practice.2024;[Epub]     CrossRef
    • Treatment Response and Safety of Herbal Medicine Combined with a Low-Carbohydrate Diet for Weight Reduction in Patients with Inflammatory Bowel Disease: A Retrospective Multicenter Study
      Ji-young Son, Su-yong Shin, Jung-sang Kim, Min-whee Kang, Dong-hun Lee, Seong-hyeon Jeon, Jun-ho Kim, Chung-hee Kim, Byung-soo Kang, Min-woo Bang
      The Journal of Internal Korean Medicine.2024; 45(6): 1136.     CrossRef
    • Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn’s Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn’s Disease (iCREST-CD)
      Takayuki Yamamoto, Hiroshi Nakase, Kenji Watanabe, Shinichiro Shinzaki, Noritaka Takatsu, Toshimitsu Fujii, Ryuichi Okamoto, Katsuyoshi Matsuoka, Akihiro Yamada, Reiko Kunisaki, Minoru Matsuura, Hisashi Shiga, Shigeki Bamba, Yohei Mikami, Takahiro Shimoya
      Journal of Crohn's and Colitis.2023; 17(8): 1193.     CrossRef
    • Alleviative mechanism and effect of Bifidobacterium animalisA6 on dextran sodium sulfate‐induced ulcerative colitis in mice
      Fang Wu, Guna Wuri, Bing Fang, Mengxuan Shi, Ming Zhang, Liang Zhao
      Food Science & Nutrition.2023; 11(2): 892.     CrossRef
    • A Retrospective Cohort Study of Clinical Features and Treatment Patterns With Ustekinumab in Patients With Crohn Disease Utilizing a Health Care Database in Japan
      Yanfang Liu, Choo Hua Goh, Hong Qiu, Kuan-Chih Huang, Hsingwen Chung, Carine Saadoun
      Annals of Pharmacotherapy.2023; 57(9): 1053.     CrossRef
    • Safety and Effectiveness of Ustekinumab for Crohn’s Disease in Japanese Post-marketing Surveillance in Biologic-Naive and -Experienced Conriemed
      Katsumasa Nagano, Erina Hata, Teita Asano, Hiroaki Tsuchiya, Masayuki Takagishi, Hiroshi Yamazaki, Sonoko Tominaga, Takayuki Matsumoto
      Crohn's & Colitis 360.2023;[Epub]     CrossRef
    • Risk factors for poor sleep quality in patients with inflammatory bowel disease in China: A multicenter study
      Suqi Zeng, Chuan Liu, Jixiang Zhang, Ping An, Zhongchun Liu, Changqing Jiang, Jie Shi, Kaichun Wu, Weiguo Dong
      Frontiers in Psychiatry.2023;[Epub]     CrossRef
    • Comparison of the Persistence of Anti-TNF Agents and Ustekinumab in Patients with Crohn’s Disease: A Study Based on the Korean National Database
      Gi Hyeon Seo, Sung Hoon Jung
      Journal of Clinical Medicine.2023; 12(6): 2397.     CrossRef
    • A review article of inflammatory bowel disease treatment and pharmacogenomics
      Nashwa Eltantawy, Islam Abd El-Hamid El-Zayyadi, Ahmed A. Elberry, Layla M. Salah, Mohamed E. A. Abdelrahim, Amira B. Kassem
      Beni-Suef University Journal of Basic and Applied Sciences.2023;[Epub]     CrossRef
    • Longitudinal trends in direct costs and healthcare utilization ascribable to inflammatory bowel disease in the biologic era: a nationwide, population‐based study
      Eun Young Park, Dong Hoon Baek, Gwang Ha Kim, Choongrak Kim, Hasung Kim, Jeong Woo Lee, Geun Am Song
      Journal of Gastroenterology and Hepatology.2023; 38(9): 1485.     CrossRef
    • Mucosal immune systems of pediatric inflammatory bowel disease: A review
      Takahiro Kudo, Toshiaki Shimizu
      Pediatrics International.2023;[Epub]     CrossRef
    • Thirty-year Trend in Inflammatory Bowel Disease on Jeju Island, South Korea
      Jin Woo Kim, Hyun Joo Song, Sun-Jin Boo, Heung Up Kim, Ki Soo Kang, Soo-Young Na
      The Korean Journal of Gastroenterology.2023; 81(6): 243.     CrossRef
    • A web-based survey on self-management for patients with inflammatory bowel disease in Japan
      Masakazu Nagahori, Takahito Imai, Mikiko Nakashoji, Ai Tairaka, Jovelle L. Fernandez, Pei-Yuan Su
      PLOS ONE.2023; 18(7): e0287618.     CrossRef
    • Vagus Nerve Stimulation Through Electro-acupuncture for Inflammatory Bowel Disease
      Minjeong Kim, Dongwon Kim, Chaehyun Park, Jae-Woo Park, Seok-Jae Ko
      The Journal of Internal Korean Medicine.2023; 44(3): 455.     CrossRef
    • Diagnosis of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
      Han Hee Lee, Jae Jun Park, Bo-In Lee, Ida Hilmi, Jose Sollano, Zhi Hua Ran
      Intestinal Research.2023; 21(3): 328.     CrossRef
    • Magnolia officinalis bark extract improves depressive-like behavior in DSS-induced colitis mice
      Min-Soo Kim, Jungim Kim, Kang-In Lee, Hye Jin Kim, Hyungjun Kim, Donghwan Kim, Ki-Sun Park
      Journal of Functional Foods.2023; 108: 105775.     CrossRef
    • Treatment Patterns in Newly Diagnosed Patients with Crohn’s Disease Who Received Biologics Following Diagnosis: A Nationwide, Retrospective, Longitudinal, Observational Study Using a Medical Claims Database in Japan
      Fumihito Hirai, Akihito Uda, Mihoko Ota, Yukiko Takemura, Keisuke Tanaka, Ryuichi Iwakiri
      Digestion.2023; 104(2): 109.     CrossRef
    • IBD barriers across the continents – East Asia
      Joyce Wing Yan Mak, Agnes Hiu Yan Ho, Siew Chien Ng
      Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
    • Lycium barbarum polysaccharide alleviates DSS-induced chronic ulcerative colitis by restoring intestinal barrier function and modulating gut microbiota
      Zhi-Yu Li, Lan-Hui Lin, He-Jun Liang, Ya-Qi Li, Fu-Qian Zhao, Ting-Yi Sun, Zi-Yu Liu, Jing-Yi Zhu, Feng Gu, Jia-Ning Xu, Qi-Yuan Hao, De-Shan Zhou, Hui-Hong Zhai
      Annals of Medicine.2023;[Epub]     CrossRef
    • Geographical heterogeneity in the disease characteristics and management of patients with inflammatory bowel disease, the preliminary results of a Chinese database for IBD (CHASE-IBD)
      Jian Wan, Jun Shen, Xiaoping Wu, Jie Zhong, Yan Chen, Lanxiang Zhu, Yinglei Miao, Naizhong Hu, Jie Chen, Jie Liang, Kaichun Wu
      Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
    • Vaccination strategies for Korean patients with inflammatory bowel disease
      Yoo Jin Lee, Eun Soo Kim
      The Korean Journal of Internal Medicine.2022; 37(5): 920.     CrossRef
    • Development and Validation of a Pediatric MRI-Based Perianal Crohn Disease (PEMPAC) Index—A Report from the ImageKids Study
      Sapir Choshen, Dan Turner, Li-Tal Pratt, Ronit Precel, Mary-Louise Greer, Denise A Castro, Amit Assa, María I Martínez-León, Izabela Herman-Sucharska, Eva Coppenrath, Osnat Konen, Jorge Davila, Elhamy Bekhit, Zehour Alsabban, Gili Focht, Matan Gavish, Ann
      Inflammatory Bowel Diseases.2022; 28(5): 700.     CrossRef
    • Beneficial effect of capsaicin via TRPV4/EDH signals on mesenteric arterioles of normal and colitis mice
      Luyun Zhang, Wei Lu, Cheng Lu, Yanjun Guo, Xiongying Chen, Jun Chen, Feng Xu, Hanxing Wan, Hui Dong
      Journal of Advanced Research.2022; 39: 291.     CrossRef
    • The Involvement of Glial Cell-Derived Neurotrophic Factor in Inflammatory Bowel Disease
      HuiLing Chen, TiYun Han, LiPing Gao, DeKui Zhang
      Journal of Interferon & Cytokine Research.2022; 42(1): 1.     CrossRef
    • Active and passive smoking and risk of ulcerative colitis: A case–control study in Japan
      Atsushi Nishikawa, Keiko Tanaka, Yoshihiro Miyake, Chisato Nagata, Shinya Furukawa, Akira Andoh, Tetsuji Yokoyama, Naoki Yoshimura, Kenichiro Mori, Tomoyuki Ninomiya, Yasunori Yamamoto, Eiji Takeshita, Yoshio Ikeda, Mitsuru Saito, Katsuhisa Ohashi, Hirots
      Journal of Gastroenterology and Hepatology.2022; 37(4): 653.     CrossRef
    • Combined Endoscopic and Radiologic Healing Is Associated With a Better Prognosis Than Endoscopic Healing Only in Patients With Crohn's Disease Receiving Anti-TNF Therapy
      Kyunghwan Oh, Eun Hye Oh, Soo Min Noh, Seong Ho Park, Nayoung Kim, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
      Clinical and Translational Gastroenterology.2022; 13(1): e00442.     CrossRef
    • Clinical Characteristics of Crohn's Disease in a Cohort from Saudi Arabia
      Yousef A. Qari
      Saudi Journal of Medicine & Medical Sciences.2022; 10(1): 56.     CrossRef
    • Shift to a Younger Age and Regional Differences in Inflammatory Bowel Disease in Korea: Using Healthcare Administrative Data
      Seo-Hee Kim, Yujin Park, Seong Pyo Kim, Sung Hee Lee, Seak Hee Oh, Suk-Kyun Yang, Hyung-Jin Yoon, Kyung Mo Kim
      Digestive Diseases and Sciences.2022; 67(11): 5079.     CrossRef
    • Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients
      Ana Gutiérrez, Pedro Zapater, Elena Ricart, María González-Vivó, Jordi Gordillo, David Olivares, Isabel Vera, Míriam Mañosa, Javier P. Gisbert, Mariam Aguas, Eugenia Sánchez-Rodríguez, Maia Bosca-Watts, Viviana Laredo, Blau Camps, Ignacio Marín-Jiménez, Y
      Frontiers in Medicine.2022;[Epub]     CrossRef
    • Screening and Evaluation of Probiotics for Reducing Intestinal Inflammation
      雅君 陈
      Hans Journal of Food and Nutrition Science.2022; 11(01): 44.     CrossRef
    • Remittance of primary cutaneous CD30+ lymphoproliferative disorder in a patient on adalimumab
      Rosanne Ottevanger, Rutger C. Melchers, Koen D. Quint
      JAAD Case Reports.2022; 22: 34.     CrossRef
    • Efficacy of Probiotics-Based Interventions as Therapy for Inflammatory Bowel Disease: A Recent Update
      Shanmugaprakasham Selvamani, Vijay Mehta, Hesham Ali El Enshasy, Suganthi Thevarajoo, Hala El Adawi, Ibrahim Zeini, Khoa Pham, Theodoros Varzakas, Bassam Abomoelak
      Saudi Journal of Biological Sciences.2022; 29(5): 3546.     CrossRef
    • Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South‐East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease‐Emerging Nations' Consortium
      Rupa Banerjee, Partha Pal, Ida Hilmi, Uday C Ghoshal, Devendra C Desai, Mohammed Masudur Rahman, Usha Dutta, Syed A Mohiuddin, Munnera Al Mohannadi, Mathew Philip, Ganesh N Ramesh, Madunil A Niriella, Arjuna P De Silva, Hithanadura Janaka de Silva, Pises
      Journal of Gastroenterology and Hepatology.2022; 37(6): 1004.     CrossRef
    • Changes in the Long-term Prognosis of Crohn’s Disease between 1986 and 2015: The Population-Based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study
      Byong Duk Ye, Sung Noh Hong, Seung In Seo, Ye-Jee Kim, Jae Myung Cha, Kyoung Hoon Rhee, Hyuk Yoon, Young-Ho Kim, Kyung Ho Kim, Sun Yong Park, Seung Kyu Jeong, Ji Hyun Lee, Hyunju Park, Joo Sung Kim, Jong Pil Im, Sung Hoon Kim, Jisun Jang, Jeong Hwan Kim,
      Gut and Liver.2022; 16(2): 216.     CrossRef
    • Capsaicin inhibits intestinal Cl- secretion and promotes Na+ absorption by blocking TRPV4 channels in healthy and colitic mice
      Hanxing Wan, Xiong Ying Chen, Fenglian Zhang, Jun Chen, Fenglan Chu, Zachary M. Sellers, Feng Xu, Hui Dong
      Journal of Biological Chemistry.2022; 298(5): 101847.     CrossRef
    • Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease
      Ji Min Lee, Shu-Chen Wei, Kang-Moon Lee, Byong Duk Ye, Ren Mao, Hyun-Soo Kim, Soo Jung Park, Sang Hyoung Park, Eun Hye Oh, Jong Pil Im, Byung Ik Jang, Dae Bum Kim, Ken Takeuchi
      Gut and Liver.2022; 16(3): 396.     CrossRef
    • The Effect of Empowering Education Combined With Mindfulness Meditation Training on Negative Emotion and Quality of Life in Patients With Inflammatory Bowel Disease
      Wei-Zhen Xi, Chong-Wu Xu, Ling-Ling Wang
      Frontiers in Behavioral Neuroscience.2022;[Epub]     CrossRef
    • The first association study of Protein Tyrosine Phosphatase, Non-Receptor Type 2 (PTPN2) gene polymorphisms in Malaysian patients with Crohn’s disease
      Xiang Ting Goh, Suh Kuan Fong, Hwa Chia Chai, Boon Pin Kee, Kek Heng Chua
      Gene.2022; 836: 146661.     CrossRef
    • The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease
      Xinwei Xu, Dickson Kofi Wiredu Ocansey, Sanhua Hang, Bo Wang, Samuel Amoah, Chengxue Yi, Xu Zhang, Lianqin Liu, Fei Mao
      Gut Pathogens.2022;[Epub]     CrossRef
    • Differences in MUC2 Gene Expression Based on the Clinical Severity of Colitis and the Degree of Histopathological Damage to the Colonic Mucosa in Colitis-induced Rat
      Saptino Miro, Arni Amir, Nasrul Zubir, Andani Eka Putra
      Open Access Macedonian Journal of Medical Sciences.2022; 10(B): 1170.     CrossRef
    • Trend and Geographic Variation in Incidence and Prevalence of Inflammatory Bowel Disease in Regions Across China: A Nationwide Employee Study Between 2013 and 2016
      Hong Yang, Runing Zhou, Xiaoyin Bai, Mingyue Guo, Gechong Ruan, Li Wang, Jiaming Qian
      Frontiers in Medicine.2022;[Epub]     CrossRef
    • Mechanism of electroacupuncture and herb-partitioned moxibustion on ulcerative colitis animal model: A study based on proteomics
      Qin Qi, Rui Zhong, Ya-Nan Liu, Chen Zhao, Yan Huang, Yuan Lu, Zhe Ma, Han-Dan Zheng, Lu-Yi Wu
      World Journal of Gastroenterology.2022; 28(28): 3644.     CrossRef
    • Evaluating macro‐ and micronutrients and food groups intake with the risk of developing inflammatory bowel disease: Is there any association?
      Farnaz Farsi, Negin Tahvilian, Azadeh Heydarian, Sara Karimi, Sara Ebrahimi, Nasser Ebrahimi‐Daryani, Sanam Tabataba‐Vakili, Javad Heshmati, Marjan Mokhtare
      Food Science & Nutrition.2022; 10(11): 3920.     CrossRef
    • Evaluation of nutritional status using bioelectrical impedance analysis in patients with inflammatory bowel disease
      Seung Hyuk Kim, You Sun Kim, Si Hyeong Lee, Hyun Mi Lee, Won Eui Yoon, Seo Hyun Kim, Hee Jun Myung, Jeong Seop Moon
      Intestinal Research.2022; 20(3): 321.     CrossRef
    • Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study
      Seung Yong Shin, Soo Jung Park, Young Kim, Jong Pil Im, Hyo Jong Kim, Kang-Moon Lee, Ji Won Kim, Sung-Ae Jung, Jun Lee, Sang-Bum Kang, Sung Jae Shin, Eun Sun Kim, You Sun Kim, Tae Oh Kim, Hyun-Soo Kim, Dong Il Park, Hyung Kil Kim, Eun Soo Kim, Young-Ho Ki
      Intestinal Research.2022; 20(3): 350.     CrossRef
    • Landscape of inflammatory bowel disease in Singapore
      Daren Low, Nidhi Swarup, Toshiyuki Okada, Emiko Mizoguchi
      Intestinal Research.2022; 20(3): 291.     CrossRef
    • Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCREST-CD)
      Katsuyoshi Matsuoka, Toshimitsu Fujii, Ryuichi Okamoto, Akihiro Yamada, Reiko Kunisaki, Minoru Matsuura, Kenji Watanabe, Hisashi Shiga, Noritaka Takatsu, Shigeki Bamba, Yohei Mikami, Takayuki Yamamoto, Takahiro Shimoyama, Satoshi Motoya, Takehiro Torisu,
      Journal of Gastroenterology.2022; 57(11): 867.     CrossRef
    • Neutralizing Antibody Response, Safety, and Efficacy of mRNA COVID-19 Vaccines in Pediatric Patients with Inflammatory Bowel Disease: A Prospective Multicenter Case—Control Study
      Kyung Jae Lee, So Yoon Choi, Yoo Min Lee, Han Wool Kim
      Vaccines.2022; 10(8): 1265.     CrossRef
    • Long-term trends in the burden of inflammatory bowel disease in China over three decades: A joinpoint regression and age-period-cohort analysis based on GBD 2019
      Yang Zhang, Jiali Liu, Xiao Han, Hui Jiang, Liming Zhang, Juncong Hu, Lei Shi, Junxiang Li
      Frontiers in Public Health.2022;[Epub]     CrossRef
    • What Are the Different Phenotypes of Inflammatory Bowel Disease in Asia?
      Su Bee Park, Jin Young Yoon, Jae Myung Cha
      Gut and Liver.2022; 16(5): 676.     CrossRef
    • Pilot study of an elimination diet in adults with mild to moderate Crohn’s disease
      Neeraj Narula, Emily C.L. Wong, Paul Moayyedi, Walter Reinisch, John K. Marshall
      European Journal of Gastroenterology & Hepatology.2022; 34(12): 1210.     CrossRef
    • Natural history of inflammatory bowel disease: a comparison between the East and the West
      Eun Mi Song, Suk-Kyun Yang
      Intestinal Research.2022; 20(4): 418.     CrossRef
    • Treatment with Extracellular Vesicles from Giardia lamblia Alleviates Dextran Sulfate Sodium-Induced Colitis in C57BL/6 Mice
      Hyun Jung Kim, Young-Ju Lee, Seon-Ok Back, Shin-Hyeong Cho, Hee-Il Lee, Myoung-Ro Lee
      The Korean Journal of Parasitology.2022; 60(5): 309.     CrossRef
    • Uptake and Advanced Therapy of Butyrate in Inflammatory Bowel Disease
      Shinji Ota, Hirotake Sakuraba
      Immuno.2022; 2(4): 692.     CrossRef
    • Long-Term Trends in the Burden of Inflammatory Bowel Disease in China Over Three Decades: A Joinpoint Regression and Age-Period-Cohort Analysis Based on GBD 2019
      Yang Zhang, Jiali Liu, Xiao Han, Hui Jiang, Liming Zhang, Juncong Hu, Lei Shi, Junxiang Li
      SSRN Electronic Journal .2022;[Epub]     CrossRef
    • Differences in inflammatory bowel diseases between East and West: a Chinese perspective
      Guanglin Cui, Junling Li, Hanzhe Liu, Jann-Birger Laugsand, Zhanju Liu
      Journal of Public Health.2021; 29(1): 19.     CrossRef
    • Structural and functional changes in the brain of patients with Crohn’s disease: an activation likelihood estimation meta-analysis
      Andy Wai Kan Yeung
      Brain Imaging and Behavior.2021; 15(2): 807.     CrossRef
    • Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia
      Zhihua Ran, Kaichun Wu, Katsuyoshi Matsuoka, Yoon Tae Jeen, Shu Chen Wei, Vineet Ahuja, Minhu Chen, Pin‐Jin Hu, Akira Andoh, Hyo Jong Kim, Suk‐Kyun Yang, Mamoru Watanabe, Siew Chien Ng, Toshifumi Hibi, Ida Normiha Hilmi, Yasuo Suzuki, Dong Soo Han, Wai Ke
      Journal of Gastroenterology and Hepatology.2021; 36(3): 637.     CrossRef
    • Exclusive enteral nutrition is effective and feasible as primary induction and re‐induction therapy in Asian children with Crohn's disease
      Kok Joo Chan, Zhi Liang Song, Kee Seang Chew, Ruey Terng Ng, Siti Hawa Mohd Taib, Way Seah Lee
      Journal of Paediatrics and Child Health.2021; 57(2): 239.     CrossRef
    • The four epidemiological stages in the global evolution of inflammatory bowel disease
      Gilaad G. Kaplan, Joseph W. Windsor
      Nature Reviews Gastroenterology & Hepatology.2021; 18(1): 56.     CrossRef
    • Zinc and Selenium in Inflammatory Bowel Disease: Trace Elements with Key Roles?
      Mostafa Vaghari-Tabari, Davoud Jafari-Gharabaghlou, Fatemeh Sadeghsoltani, Parisa Hassanpour, Durdi Qujeq, Nadereh Rashtchizadeh, Amir Ghorbanihaghjo
      Biological Trace Element Research.2021; 199(9): 3190.     CrossRef
    • Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia
      Shu-Chen Wei, Jose Sollano, Yee Tak Hui, Wei Yu, Paul V. Santos Estrella, Lyndon John Q. Llamado, Nana Koram
      Expert Review of Gastroenterology & Hepatology.2021; 15(3): 275.     CrossRef
    • Mycosis fungoides in a patient with ulcerative colitis on anti-tumor necrosis factor-alpha therapy
      Takeshi Yasuda, Tomohisa Takagi, Jun Asai, Norito Katoh, Junya Kuroda, Yasumichi Kuwahara, Yukiko Morinaga, Eiichi Konishi, Kazuhiko Uchiyama, Yuji Naito, Yoshito Itoh
      Clinical Journal of Gastroenterology.2021; 14(1): 170.     CrossRef
    • The Response of the Tongue Epithelial on Cigarette Smoke Exposure as a Risk Factor for Oral Cancer Development
      Neken Prasetyaningtyas, Nabilah Azzahra Jatiatmaja, Desiana Radithia, Hening Tuti Hendarti, Adiastuti Endah Parmadiati, Priyo Hadi, Fatma Yasmin Mahdani, Diah Savitri Ernawati, Rosnah binti Zain, Nurina Febriyanti Ayuningtyas
      European Journal of Dentistry.2021; 15(02): 320.     CrossRef
    • Racial disparities exist in surgical outcomes for patients with inflammatory bowel disease
      Isabel C. Dos Santos Marques, Lauren M. Theiss, Lauren N. Wood, Drew J. Gunnells, Robert H. Hollis, Karin M. Hardiman, Jamie A. Cannon, Melanie S. Morris, Gregory D. Kennedy, Daniel I. Chu
      The American Journal of Surgery.2021; 221(4): 668.     CrossRef
    • Astragalin Inhibits Nuclear Factor-κB Signaling in Human Colonic Epithelial Cells and Attenuates Experimental Colitis in Mice
      Yoo Min Han, Jaemoon Koh, Jee Hyun Kim, Jooyoung Lee, Jong Pil Im, Joo Sung Kim
      Gut and Liver.2021; 15(1): 100.     CrossRef
    • Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease
      Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
      Gut and Liver.2021; 15(1): 92.     CrossRef
    • Clinical Outcomes and Response Predictors of Vedolizumab Induction Treatment for Korean Patients With Inflammatory Bowel Diseases Who Failed Anti-TNF Therapy: A KASID Prospective Multicenter Cohort Study
      Jeongseok Kim, Hyuk Yoon, Nayoung Kim, Kang-Moon Lee, Sung-Ae Jung, Chang Hwan Choi, Eun Soo Kim, Yunho Jung, Chang Soo Eun, Tae Oh Kim, Sang-Bum Kang, You Sun Kim, Geom-Seog Seo, Chang Kyun Lee, Jong Pil Im, Soo Jung Park, Dong Il Park, Byong Duk Ye
      Inflammatory Bowel Diseases.2021; 27(12): 1931.     CrossRef
    • Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis
      Toshifumi Hibi, Isao Kamae, Philippe Pinton, Lyann Ursos, Ryuichi Iwakiri, Greg Hather, Haridarshan Patel
      Intestinal Research.2021; 19(1): 53.     CrossRef
    • Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet’s disease in Japan
      Yutaro Soejima, Yohei Kirino, Mitsuhiro Takeno, Michiko Kurosawa, Masaki Takeuchi, Ryusuke Yoshimi, Yumiko Sugiyama, Shigeru Ohno, Yukiko Asami, Akiko Sekiguchi, Toshihisa Igarashi, Shohei Nagaoka, Yoshiaki Ishigatsubo, Hideaki Nakajima, Nobuhisa Mizuki
      Arthritis Research & Therapy.2021;[Epub]     CrossRef
    • Differential effects of EPA and DHA on DSS-induced colitis in mice and possible mechanisms involved
      Zhuangwei Zhang, Zhe Xue, Haitao Yang, Feng Zhao, Chundi Liu, Jiahui Chen, Songtao Lu, Zuquan Zou, Yuping Zhou, Xiaohong Zhang
      Food & Function.2021; 12(4): 1803.     CrossRef
    • Proteinuria Is Associated with the Development of Crohn’s Disease: A Nationwide Population-Based Study
      Seona Park, Hyun Jung Lee, Kyung-Do Han, Hosim Soh, Jung Min Moon, Seung Wook Hong, Eun Ae Kang, Jong Pil Im, Joo Sung Kim
      Journal of Clinical Medicine.2021; 10(4): 799.     CrossRef
    • Maternal Emulsifier P80 Intake Induces Gut Dysbiosis in Offspring and Increases Their Susceptibility to Colitis in Adulthood
      Ge Jin, Qiang Tang, Jiaheng Ma, Xiang Liu, Bingqian Zhou, Yue Sun, Xiaoqi Pang, Zixuan Guo, Runxiang Xie, Tianyu Liu, Bangmao Wang, Hailong Cao, Hongwei Zhou
      mSystems.2021;[Epub]     CrossRef
    • Effect of MicroRNA145 on the multidrug resistance gene of ulcerative colitis in rats
      Ping Wang, Yan Chen, La-Mei Zhang, Si-Qi Yuan, Shen-Ao Lu, Ying-Jian Zhang
      Life Sciences.2021; 278: 119603.     CrossRef
    • Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study
      Neeraj Narula, Emily C L Wong, Mahshid Dehghan, Andrew Mente, Sumathy Rangarajan, Fernando Lanas, Patricio Lopez-Jaramillo, Priyanka Rohatgi, P V M Lakshmi, Ravi Prasad Varma, Andres Orlandini, Alvaro Avezum, Andreas Wielgosz, Paul Poirier, Majid A Almadi
      BMJ.2021; : n1554.     CrossRef
    • Evaluation of economic burden with biologic treatments in Crohn’s disease patients: A mirror image study using an insurance database in Japan
      Celine Miyazaki, Nagano Katsumasa, Kuan Chih Huang, Yan Fang Liu, Kevin Lu
      PLOS ONE.2021; 16(7): e0254807.     CrossRef
    • Safety and effectiveness of ustekinumab in Crohn's disease: Interim results of post‐marketing surveillance in Japan
      Seiji Yokoyama, Teita Asano, Katsumasa Nagano, Hiroaki Tsuchiya, Masayuki Takagishi, Shigeharu Tsujioka, Naomi Miura, Takayuki Matsumoto
      Journal of Gastroenterology and Hepatology.2021; 36(11): 3069.     CrossRef
    • Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis
      Shin Ju Oh, Ga Young Shin, Hosim Soh, Jae Gon Lee, Jong Pil Im, Chang Soo Eun, Kang-Moon Lee, Dong Il Park, Dong Soo Han, Hyo Jong Kim, Chang Kyun Lee
      Intestinal Research.2021; 19(3): 323.     CrossRef
    • Endoscopy within 7 days after detecting high calprotectin levels can be useful for therapeutic decision-making in ulcerative colitis
      Ho Min Yong, Sung-Jo Park, Seong Ran Jeon, Heesu Park, Hyun Gun Kim, Tae Hee Lee, Junseok Park, Jin-Oh Kim, Joon Seong Lee, Bong Min Ko, Hyeon Jeong Goong, Suyeon Park
      Medicine.2021; 100(34): e27065.     CrossRef
    • Epidemiology and diagnosis of inflammatory bowel diseases
      Kang-Moon Lee
      Journal of the Korean Medical Association.2021; 64(9): 579.     CrossRef
    • MiRNA-182-5p aggravates experimental ulcerative colitis via sponging Claudin-2
      Siwen Tang, Wentao Guo, Liumin Kang, Jinghua Liang
      Journal of Molecular Histology.2021; 52(6): 1215.     CrossRef
    • Incident Crohn’s Disease as a Risk Factor for Colorectal Cancer in the First 10 Years after Diagnosis: A Nationwide Population-Based Study
      Hyunil Kim, Ji Hoon Kim, Jung Kuk Lee, Dae Ryong Kang, Su Young Kim, Hyun-Soo Kim, Hee Man Kim
      Journal of Clinical Medicine.2021; 10(20): 4663.     CrossRef
    • Machine learning for prediction of intra-abdominal abscesses in patients with Crohn’s disease visiting the emergency department
      Asaf Levartovsky, Yiftach Barash, Shomron Ben-Horin, Bella Ungar, Shelly Soffer, Marianne M. Amitai, Eyal Klang, Uri Kopylov
      Therapeutic Advances in Gastroenterology.2021;[Epub]     CrossRef
    • Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study
      Tadakazu Hisamatsu, Yasuo Suzuki, Mariko Kobayashi, Takashi Hagiwara, Takeshi Kawaberi, Haruhiko Ogata, Toshiyuki Matsui, Mamoru Watanabe, Toshifumi Hibi
      Intestinal Research.2021; 19(4): 408.     CrossRef
    • Exploring Links Between Industrialization, Urbanization, and Chinese Inflammatory Bowel Disease
      Guanglin Cui, Hanzhe Liu, Gang Xu, Jann-Birger Laugsand, Zhigang Pang
      Frontiers in Medicine.2021;[Epub]     CrossRef
    • Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerative colitis: a subpopulation analysis of global phase 3 induction and maintenance studies (UNIFI)
      Tadakazu Hisamatsu, Hyo Jong Kim, Satoshi Motoya, Yasuo Suzuki, Yoshifumi Ohnishi, Noriyuki Fujii, Nobuko Matsushima, Richuan Zheng, Colleen W. Marano
      Intestinal Research.2021; 19(4): 386.     CrossRef
    • Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study
      Haruhiko Ogata, Takashi Hagiwara, Takeshi Kawaberi, Mariko Kobayashi, Toshifumi Hibi
      Intestinal Research.2021; 19(4): 419.     CrossRef
    • Real-World Incidence of Suboptimal Response to Anti-Tumor Necrosis Factor Therapy for Ulcerative Colitis: A Nationwide Population-Based Study
      Ju-Young Shin, Hye-Min Park, Min-Young Lee, Ja-Young Jeon, Hyun-Jeong Yoo, Byong Duk Ye
      Gut and Liver.2021; 15(6): 867.     CrossRef
    • Clinical Remission of Crohn’s Disease Induced by Herbal Decoction (Jinmoo-tang): A Case Report
      Byunghee Lee, Jiyoon Won, Hyangsook Lee
      Journal of Physiology & Pathology in Korean Medicine.2021; 35(6): 255.     CrossRef
    • Incidence and risk factors of Pneumocystis jirovecii pneumonia in Korean patients with inflammatory bowel disease
      Kwangwoo Nam, Sang Hyoung Park, Junghwan Lee, Seokjung Jo, Seon‐Ok Kim, Soomin Noh, Jae Cheol Park, Jin Yong Kim, Jeongseok Kim, Nam Seok Ham, Eun Hye Oh, Eun Mi Song, Sung Wook Hwang, Dong‐Hoon Yang, Byong Duk Ye, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Ky
      Journal of Gastroenterology and Hepatology.2020; 35(2): 218.     CrossRef
    • Potential influential factors on incidence and prevalence of inflammatory bowel disease in mainland China
      Yuqi Qiao, Zhihua Ran
      JGH Open.2020; 4(1): 11.     CrossRef
    • Cost-Effectiveness Analysis of Vedolizumab Compared with Other Biologics in Anti-TNF-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan
      Luis Hernandez, Hiroyo Kuwabara, Anshul Shah, Kaoru Yamabe, Heather Burnett, Kyle Fahrbach, Maria Koufopoulou, Ryuichi Iwakiri
      PharmacoEconomics.2020; 38(1): 69.     CrossRef
    • Nutritional and dietary strategy in the clinical care of inflammatory bowel disease
      Meng-Shu Hsieh, Wen-Hung Hsu, Jiunn-Wei Wang, Yao-Kuang Wang, Huang-Ming Hu, Wei-Kuo Chang, Chih-Yen Chen, Deng-Chyang Wu, Fu-Chen Kuo, Wei-Wen Su
      Journal of the Formosan Medical Association.2020; 119(12): 1742.     CrossRef
    • UK Patients of Bangladeshi Descent with Crohn’s Disease Respond Less Well to TNF Antagonists Than Caucasian Patients
      Radha Gadhok, Hannah Gordon, Gregory Sebepos-Rogers, Samantha Baillie, Saniath Akbar, Jane E. Abbott, Emma Michael, Omer F. Ahmad, Ben Cooper, James O. Lindsay
      Digestive Diseases and Sciences.2020; 65(6): 1790.     CrossRef
    • Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study
      Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
      Digestive Diseases and Sciences.2020; 65(5): 1436.     CrossRef
    • Intestinal Epithelial Deletion of Sphk1 Prevents Colitis-Associated Cancer Development by Inhibition of Epithelial STAT3 Activation
      Seung Bin Park, Byung-il Choi, Beom Jae Lee, Nam Joo Kim, Yoon A. Jeong, Moon Kyung Joo, Hyo Jung Kim, Jong-Jae Park, Jae Seon Kim, Yoon-Seok Noh, Hyun Joo Lee
      Digestive Diseases and Sciences.2020; 65(8): 2284.     CrossRef
    • High-fat diet-derived free fatty acids impair the intestinal immune system and increase sensitivity to intestinal epithelial damage
      Shohei Tanaka, Yasuhiro Nemoto, Yuria Takei, Ryo Morikawa, Shigeru Oshima, Takashi Nagaishi, Ryuichi Okamoto, Kiichiro Tsuchiya, Tetsuya Nakamura, Susanne Stutte, Mamoru Watanabe
      Biochemical and Biophysical Research Communications.2020; 522(4): 971.     CrossRef
    • Effects of vedolizumab in Japanese patients with Crohn’s disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses
      Kenji Watanabe, Satoshi Motoya, Haruhiko Ogata, Takanori Kanai, Toshiyuki Matsui, Yasuo Suzuki, Mitsuhiro Shikamura, Kenkichi Sugiura, Kazunori Oda, Tetsuharu Hori, Takahiro Araki, Mamoru Watanabe, Toshifumi Hibi
      Journal of Gastroenterology.2020; 55(3): 291.     CrossRef
    • Predictors of long-term outcomes of radiologically defined perianal fistulizing Crohn’s disease treated with antitumor necrosis factor-alpha agents based on Parks’ classification
      Nahla Azzam, Othman Alharbi, Majid Almadi, Abdulrahman Aljebreen, Turki AlAmeel, Mohammed Alabbas, Salman Bahammam, Ahmed Bashmail, Yasser Alomar, Mahmoud Mosli
      European Journal of Gastroenterology & Hepatology.2020; 32(2): 187.     CrossRef
    • Comparison of Real-World Outcomes of Infliximab versus Adalimumab in Biologic-Naïve Korean Patients with Ulcerative Colitis: A Population-Based Study
      Minkyung Han, Yoon Suk Jung, Jae Hee Cheon, Sohee Park
      Yonsei Medical Journal.2020; 61(1): 48.     CrossRef
    • Nicotine-induced autophagy via AMPK/mTOR pathway exerts protective effect in colitis mouse model
      Qian Gao, Pinduan Bi, Ding Luo, Ying Guan, Wanli Zeng, Haiying Xiang, Qili Mi, Guangyu Yang, Xuemei Li, Bin Yang
      Chemico-Biological Interactions.2020; 317: 108943.     CrossRef
    • Emerging Involvement of long non-coding RNAs in gastrointestinal associated inflammatory disorders
      Hamed Esmaeil Lashgarian, Maryam Karkhane, Abdolrazagh Marzban, Mohammad Yazdi, Kiana Shahzamani
      Comparative Immunology, Microbiology and Infectious Diseases.2020; 69: 101428.     CrossRef
    • Changes in Direct Healthcare Costs before and after the Diagnosis of Inflammatory Bowel Disease: A Nationwide Population-Based Study
      Jooyoung Lee, Jong Pil Im, Kyungdo Han, Jihye Kim, Hyun Jung Lee, Jaeyoung Chun, Joo Sung Kim
      Gut and Liver.2020; 14(1): 89.     CrossRef
    • Trends in Healthcare Costs for Inflammatory Bowel Disease in South Korea
      Yoon Suk Jung
      Gut and Liver.2020; 14(1): 3.     CrossRef
    • Role of microRNA-449a in the progress of inflammatory bowel disease in children
      Dandan Zhao, Na Wu, Libo Wang, Xiaoli Pang, Xuehua Liu, Xiaohong Zhang
      Biotechnology & Biotechnological Equipment.2020; 34(1): 144.     CrossRef
    • Lovastatin derivative dehydrolovastatin ameliorates ulcerative colitis in mice by suppressing NF-κB and inflammatory cytokine expression
      Xu Zhang, Qing-Hua Deng, Jian-Hua Deng, Sheng-Ju Wang, Qiu Chen
      The Korean Journal of Physiology & Pharmacology.2020; 24(2): 137.     CrossRef
    • Evaluation of the Optimal Position for Vedolizumab in the Japanese Treatment Paradigm for Ulcerative Colitis Using Markov Modeling
      Akihito Uda, Yuki Eto, Yuxin Li, Hiroyuki Matsuda, Sven Demiya, Tomoyuki Watanabe, Mihoko Ota, Ryuichi Iwakiri, Ataru Igarashi
      Crohn's & Colitis 360.2020;[Epub]     CrossRef
    • Effect of Berberine from Coptis chinensis on Apoptosis of Intestinal Epithelial Cells in a Mouse Model of Ulcerative Colitis: Role of Endoplasmic Reticulum Stress
      Shen Yan, Liu Yingchao, Wang Zhangliu, Ruan Xianli, Li Si, Ni Siyi, Zhong Jihong, Sokcheon Pak
      Evidence-Based Complementary and Alternative Medicine.2020;[Epub]     CrossRef
    • Ethanol extract of Pycnoporus sanguineus relieves the dextran sulfate sodium-induced experimental colitis by suppressing helper T cell-mediated inflammation via apoptosis induction
      Xiaohong Chen, Muxia Li, Dan Li, Ting Luo, Yizhen Xie, Liang Gao, Yifan Zhang, Shaodan Chen, Shunxian Li, Guoxin Huang, Wenzhi Li, Jiyan Su, Xiaoping Lai
      Biomedicine & Pharmacotherapy.2020; 127: 110212.     CrossRef
    • Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review
      Ming Han Cha, Miguel Regueiro, Dalbir S Sandhu
      World Journal of Gastroenterology.2020; 26(19): 2323.     CrossRef
    • Preoperative hypoalbuminemia is an independent risk factor for postoperative complications in Crohn's disease patients with normal BMI: A cohort study
      Xiaolong Ge, Huaying Liu, Shasha Tang, Yan Wu, Yipeng Pan, Wei Liu, Weilin Qi, Lingna Ye, Qian Cao, Wei Zhou
      International Journal of Surgery.2020; 79: 294.     CrossRef
    • Patterns of Ulcerative Colitis Treatments and Factors Affecting the Prescribing of Systemic Corticosteroid using Health Insurance Claims Database
      Jiyool Kim, So-Hee Park, Ju-Young Shin
      Korean Journal of Clinical Pharmacy.2020; 30(2): 102.     CrossRef
    • Polysaccharide isolated from Auricularia auricular‐judae (Bull.) prevents dextran sulfate sodium‐induced colitis in mice through modulating the composition of the gut microbiota
      Di Zhao, Wenjing Dai, Heng Tao, Wei Zhuang, Mi Qu, Ya‐Ning Chang
      Journal of Food Science.2020; 85(9): 2943.     CrossRef
    • Hepatobiliary manifestations in children with inflammatory bowel disease: A single-center experience in a low/middle income country
      Mortada HF El-Shabrawi, Sara Tarek, Maha Abou-Zekri, Safa Meshaal, Afaf Enayet, Engy Adel Mogahed
      World Journal of Gastrointestinal Pharmacology and Therapeutics.2020; 11(3): 48.     CrossRef
    • Is the rise in Crohn’s disease in India accompanied by a fall in intestinal tuberculosis? A single-center experience
      Pavan Dhoble, Devendra Desai, Philip Abraham
      Indian Journal of Tuberculosis.2020;[Epub]     CrossRef
    • Relapse rate following withdrawal of anti-TNF therapy in patients with inflammatory bowel disease: A real-life cohort from northern India
      Pabitra Sahu, Sudheer K. Vuyyuru, Bhaskar Kante, Ashish Agarwal, Raju Sharma, Prasenjit Das, Rajesh Panwar, Saransh Jain, Sawan Bopanna, Govind Makharia, Saurabh Kedia, Vineet Ahuja
      Indian Journal of Gastroenterology.2020; 39(4): 388.     CrossRef
    • The effect of miRNA and autophagy on colorectal cancer
      Jiali Long, Qinglian He, Yuting Yin, Xue Lei, Ziqi Li, Wei Zhu
      Cell Proliferation.2020;[Epub]     CrossRef
    • Periodontitis combined with smoking increases risk of the ulcerative colitis: A national cohort study
      Eun Ae Kang, Jaeyoung Chun, Jee Hyun Kim, Kyungdo Han, Hosim Soh, Seona Park, Seung Wook Hong, Jung Min Moon, Jooyoung Lee, Hyun Jung Lee, Jun-Beom Park, Jong Pil Im, Joo Sung Kim
      World Journal of Gastroenterology.2020; 26(37): 5661.     CrossRef
    • An assessment of dietary intake, food avoidance and food beliefs in patients with ulcerative colitis of different disease status
      Nor Hamizah Shafiee, Zahara Abdul Manaf, Norfilza M. Mokhtar, Raja Affendi Raja Ali
      Intestinal Research.2020; 18(4): 447.     CrossRef
    • Clinical management for small bowel of Crohn’s disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesion
      Kenji Watanabe
      Intestinal Research.2020; 18(4): 347.     CrossRef
    • Prediction of Recurrent Emergency Department Visits among Patients with Crohn’s Disease: A Retrospective Study
      Hussein Mahajna, Yiftach Barash, Bella Ungar, Shelly Soffer, Ahmad Albshesh, Asaf Levartovsky, Shomron Ben-Horin, Eyal Klang, Uri Kopylov
      Journal of Clinical Medicine.2020; 9(11): 3651.     CrossRef
    • Preconception Care Program for Women with Inflammatory Bowel Disease Using Intervention Mapping: A Protocol for Program Development
      Young Jin Lee, Yeon Hee Kim, Hae Won Kim
      International Journal of Environmental Research and Public Health.2020; 17(24): 9365.     CrossRef
    • Walnut phenolic extract inhibits nuclear factor kappaB signaling in intestinal epithelial cells, and ameliorates experimental colitis and colitis-associated colon cancer in mice
      Seong-Joon Koh, Youn-I Choi, Yuri Kim, Yoo-Sun Kim, Sang Woon Choi, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee
      European Journal of Nutrition.2019; 58(4): 1603.     CrossRef
    • Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study
      Hsu-Heng Yen, Meng-Tzu Weng, Chien-Chih Tung, Yu-Ting Wang, Yuan Ting Chang, Chin-Hao Chang, Ming-Jium Shieh, Jau-Min Wong, Shu-Chen Wei
      Intestinal Research.2019; 17(1): 54.     CrossRef
    • 5‐Hydroxytryptamine (5‐HT)‐exacerbated DSS‐induced colitis is associated with elevated NADPH oxidase expression in the colon
      Shizhen Dong, Menglu Chen, Faliang Dai, Qingxia Xuan, Pan Chen, Dandan Feng, Lei Gao, Chendi Zhu, Yongchao Chang, Fong‐Fong Chu, Qiang Gao
      Journal of Cellular Biochemistry.2019; 120(6): 9230.     CrossRef
    • Emerging trends of inflammatory bowel disease in South Korea: A nationwide population‐based study
      Min Seob Kwak, Jae Myung Cha, Hun Hee Lee, Yong Sung Choi, Seung In Seo, Kyung Jin Ko, Dong Il Park, Sung Hun Kim, Tae Jun Kim
      Journal of Gastroenterology and Hepatology.2019; 34(6): 1018.     CrossRef
    • Vitamin D deficiency is associated with disease activity in patients with Crohn’s disease
      Kyoung Ho Ko, You Sun Kim, Bo Kyung Lee, Jong Hyun Choi, Yong Moon Woo, Jin Young Kim, Jeong Seop Moon
      Intestinal Research.2019; 17(1): 70.     CrossRef
    • Can We Estimate Quality of Life in Pediatric Inflammatory Bowel Disease Patients? An Asian Multicenter Study
      Seung Kim, Sowon Park, Yunkoo Kang, Jung Eun Kim, Ben Kang, Byung‐Ho Choe, Yeoun Joo Lee, Jae Hong Park, Hye Ran Yang, Sung Hee Lee, Kyung Mo Kim, Eell Ryoo, Hann Tchah, Jung Ok Shim, Hong Koh
      Journal of Pediatric Gastroenterology and Nutrition.2019; 68(1): 45.     CrossRef
    • Detection and management of early stage inflammatory bowel disease: an update for clinicians
      Laura Loy, Giulia Roda, Gionata Fiorino, Mariangela Allocca, Federica Furfaro, Marjorie Argollo, Laurent Peyrin-Biroulet, Silvio Danese
      Expert Review of Gastroenterology & Hepatology.2019; 13(6): 547.     CrossRef
    • Anti-inflammatory effects of mulberry twig extracts on dextran sulfate sodium-induced colitis mouse model
      Xuelei Cui, Eunjung Kim
      Journal of Nutrition and Health.2019; 52(2): 139.     CrossRef
    • A 30-year Trend Analysis in the Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District of Seoul, Korea in 1986–2015
      Sang Hyoung Park, Ye-Jee Kim, Kyoung Hoon Rhee, Young-Ho Kim, Sung Noh Hong, Kyung Ho Kim, Seung In Seo, Jae Myung Cha, Sun Yong Park, Seung Kyu Jeong, Ji Hyun Lee, Hyunju Park, Joo Sung Kim, Jong Pil Im, Hyuk Yoon, Sung Hoon Kim, Jisun Jang, Jeong Hwan K
      Journal of Crohn's and Colitis.2019; 13(11): 1410.     CrossRef
    • Dose–response relationship between cigarette smoking and risk of ulcerative colitis: a nationwide population-based study
      Seona Park, Jaeyoung Chun, Kyung-Do Han, Hosim Soh, Eun Ae Kang, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim
      Journal of Gastroenterology.2019; 54(10): 881.     CrossRef
    • A Real-World Analysis of Prescribing Patterns and Non-persistence of Anti-TNFα Therapy for Inflammatory Bowel Disease
      Eun Jin Jang, Jung Eun Ha, Seul Gi Im, Myeong Gyu Kim, Hyun Soon Sohn
      Clinical Drug Investigation.2019; 39(7): 625.     CrossRef
    • Exposure of the Host-Associated Microbiome to Nutrient-Rich Conditions May Lead to Dysbiosis and Disease Development—an Evolutionary Perspective
      Tim Lachnit, Thomas C. G. Bosch, Peter Deines, Margaret J. McFall-Ngai
      mBio.2019;[Epub]     CrossRef
    • Inflammatory bowel disease incidence, prevalence and 12‐month initial disease course in Tasmania, Australia
      Rajesh Bhatia, Sern Wei Yeoh, Karl Vaz, Corrie Studd, Jarrad Wilson, Sally Bell, Petr Otahal, Alison Venn
      Internal Medicine Journal.2019; 49(5): 622.     CrossRef
    • Crohn’s Disease: Potential Drugs for Modulation of Autophagy
      Nursyuhada Azzman
      Medicina.2019; 55(6): 224.     CrossRef
    • Systematic review with meta‐analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease
      Adam Tepler, Neeraj Narula, Richard M. Peek, Anish Patel, Cyrus Edelson, Jean‐Frederic Colombel, Shailja C. Shah
      Alimentary Pharmacology & Therapeutics.2019; 50(2): 121.     CrossRef
    • A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia
      Norfilza Mohd Mokhtar, Khairul Najmi Muhammad Nawawi, Jaarvis Verasingam, Wong Zhiqin, Ismail Sagap, Zairul Azwan Mohd Azman, Luqman Mazlan, Hamzaini Abdul Hamid, Nur Yazmin Yaacob, Isa Mohamed Rose, Eden Low Ngah Den, Mah Suit Wan, Raja Affendi Raja Ali
      BMC Public Health.2019;[Epub]     CrossRef
    • Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study
      You-Jung Choi, Eue-Keun Choi, Kyung-Do Han, Jiesuck Park, Inki Moon, Euijae Lee, Won-Seok Choe, So-Ryoung Lee, Myung-Jin Cha, Woo-Hyun Lim, Seil Oh
      World Journal of Gastroenterology.2019; 25(22): 2788.     CrossRef
    • Emotional dysfunction and inflammatory bowel disease
      Si-Hui Li, Qiao-Feng Wu
      World Chinese Journal of Digestology.2019; 27(12): 727.     CrossRef
    • Medication Use and Drug Expenditure in Inflammatory Bowel Disease: based on Korean National Health Insurance Claims Data (2010-2014)
      Jung Eun Ha, Eun Jin Jang, Seul Gi Im, Hyun Soon Sohn
      Korean Journal of Clinical Pharmacy.2019; 29(2): 79.     CrossRef
    • Effects of flaxseed and flaxseed oil supplement on serum levels of inflammatory markers, metabolic parameters and severity of disease in patients with ulcerative colitis
      Nava Morshedzadeh, Shabnam Shahrokh, Hamid Asadzadeh Aghdaei, Mohamad Amin Pourhoseingholi, Vahid Chaleshi, Azita Hekmatdoost, Soheila Karimi, Mohammad Reza Zali, Parvin Mirmiran
      Complementary Therapies in Medicine.2019; 46: 36.     CrossRef
    • Patients with inflammatory bowel disease have an increased risk of myocardial infarction: a nationwide study
      Yoon Jin Choi, Dong Ho Lee, Dong Woo Shin, Kyung‐Do Han, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim
      Alimentary Pharmacology & Therapeutics.2019; 50(7): 769.     CrossRef
    • Taraxacum officinale extract ameliorates dextran sodium sulphate‐induced colitis by regulating fatty acid degradation and microbial dysbiosis
      Wei Chen, Huining Fan, Rui Liang, Rui Zhang, Jing Zhang, Jinshui Zhu
      Journal of Cellular and Molecular Medicine.2019; 23(12): 8161.     CrossRef
    • Marked regional variations in the prevalence of inflammatory bowel disease in a limited geographical region are not associated with compounds in the drinking water
      Fredrik Segerman, Spencer Clarkson, Klas Sjöberg
      Scandinavian Journal of Gastroenterology.2019; 54(10): 1250.     CrossRef
    • Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome
      Simon Ghaly, Prue H. Hart, Ian C Lawrance
      Expert Review of Gastroenterology & Hepatology.2019; 13(11): 1039.     CrossRef
    • Prognosis of synchronous colorectal carcinoma compared to solitary colorectal carcinoma: a matched pair analysis
      Wanbin He, Chengjun Zheng, Yonghong Wang, Jie Dan, Mingjie Zhu, Mingtian Wei, Jian Wang, Ziqiang Wang
      European Journal of Gastroenterology & Hepatology.2019; 31(12): 1489.     CrossRef
    • Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide, population-based study
      Jooyoung Lee, Jong Pil Im, Kyungdo Han, Seona Park, Hosim Soh, Kukhwan Choi, Jihye Kim, Jaeyoung Chun, Joo Sung Kim
      World Journal of Gastroenterology.2019; 25(42): 6354.     CrossRef
    • Huang-Lian-Jie-Du Decoction Ameliorates Acute Ulcerative Colitis in Mice via Regulating NF-κB and Nrf2 Signaling Pathways and Enhancing Intestinal Barrier Function
      Ziwen Yuan, Lihong Yang, Xiaosong Zhang, Peng Ji, Yongli Hua, Yanming Wei
      Frontiers in Pharmacology.2019;[Epub]     CrossRef
    • The prevalence and risk factors of psychological disorders, malnutrition and quality of life in IBD patients
      Qin Cao, Yu-Hong Huang, Min Jiang, Cong Dai
      Scandinavian Journal of Gastroenterology.2019; 54(12): 1458.     CrossRef
    • Trends and risk factors of mortality analysis in patients with inflammatory bowel disease: a Taiwanese nationwide population-based study
      Wei-Chen Lin, Meng-Tzu Weng, Chien-Chih Tung, Yuan-Ting Chang, Yew-Loong Leong, Yu-Ting Wang, Horng-Yuan Wang, Jau-Min Wong, Shu-Chen Wei
      Journal of Translational Medicine.2019;[Epub]     CrossRef
    • Knowledge and Viewpoints on Biosimilar Monoclonal Antibodies among Asian Physicians: Comparison with European Physicians
      Soo-Kyung Park, Won Moon, Eun Soo Kim, Sang Hyun Park, Dong Il Park
      The Korean Journal of Gastroenterology.2019; 74(6): 333.     CrossRef
    • BIOSAFETY OF THE FAR EAST REGION OF RUSSIA: EPIDEMIOLOGICAL AND EPIZOOTIC TRENDS
      Natalya A. Kuznetsova, B. G Andryukov
      Epidemiology and Infectious Diseases.2019; 24(3): 128.     CrossRef
    • Colonoscopic abnormalities in patients with IBD in a referral hospital in Salvador - Bahia
      Carlos Ramon Silveira Mendes, Taísa Maria Brito Amorim, Lana Ferreira Moreira, Rafaela Mendonça Leal, Adriana Conceição de Mello Andrade
      Gastroenterology & Hepatology: Open Access.2019;[Epub]     CrossRef
    • Switching off Inflammation with Diet: A Review of Exclusive Enteral Nutrition in Children with Crohn’s Disease
      Andrew S. Day
      EMJ Gastroenterology.2019; : 86.     CrossRef
    • The Role of Autophagy and Related MicroRNAs in Inflammatory Bowel Disease
      Shiyuan Wang, Yan Huang, Cili Zhou, Huangan Wu, Jimeng Zhao, Luyi Wu, Min Zhao, Fang Zhang, Huirong Liu
      Gastroenterology Research and Practice.2018; 2018: 1.     CrossRef
    • Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis
      Sedigheh Pouya, Maryam Heidari, Kaveh Baghaei, Hamid Asadzadeh Aghdaei, Afshin Moradi, Saeed Namaki, Mohammad Reza Zali, Seyed Mahmoud Hashemi
      International Immunopharmacology.2018; 54: 86.     CrossRef
    • Characteristics and Incidence Trends for Pediatric Inflammatory Bowel Disease in Daegu-Kyungpook Province in Korea: a Multi-Center Study
      Suk Jin Hong, Seung Man Cho, Byung-Ho Choe, Hyo Jeong Jang, Kwang Hae Choi, Ben Kang, Jung Eun Kim, Jun Hyun Hwang
      Journal of Korean Medical Science.2018;[Epub]     CrossRef
    • A Systematic Review of Epidemiology and Risk Factors Associated With Chinese Inflammatory Bowel Disease
      Guanglin Cui, Aping Yuan
      Frontiers in Medicine.2018;[Epub]     CrossRef
    • Herb-partitioned moxibustion alleviates colon injuries in ulcerative colitis rats
      Dan Zhang, Yan-Bo Ren, Kai Wei, Jue Hong, Yan-Ting Yang, Li-Jie Wu, Ji Zhang, Zheng Shi, Huan-Gan Wu, Xiao-Peng Ma
      World Journal of Gastroenterology.2018; 24(30): 3384.     CrossRef
    • How to Optimally Use Currently Available Drugs in a Therapeutic Algorithm?
      You Sun Kim
      The Korean Journal of Gastroenterology.2018; 71(2): 74.     CrossRef
    • Disease Activity Patterns Recorded Using a Mobile Monitoring System Are Associated with Clinical Outcomes of Patients with Crohn’s Disease
      Eun Soo Kim, Sung Kook Kim, Byung Ik Jang, Kyeong Ok Kim, Eun Young Kim, Yoo Jin Lee, Hyun Seok Lee, Sang Gyu Kwak
      Digestive Diseases and Sciences.2018; 63(9): 2220.     CrossRef
    • Efficacy of herb-partitioned moxibustion at Qihai (CV 6) and bilateral Tianshu (ST 25) on colonic damage and the TLR4/NF-κB signaling pathway in rats with Crohn's disease
      Zhang Dan, Wei Kai, Ma Xiaopeng, Wu Huangan, Hong Jue, Zhang Cuihong, Wu Lingxiang, Yan Huang, Liu Jie, Zhu Yi, Yang Ling
      Journal of Traditional Chinese Medicine.2018; 38(2): 218.     CrossRef
    • Novel treatments for inflammatory bowel disease
      Hyo Sun Lee, Soo-Kyung Park, Dong Il Park
      The Korean Journal of Internal Medicine.2018; 33(1): 20.     CrossRef
    • Rapid rise in the incidence and clinical characteristics of pediatric inflammatory bowel disease in a South–East Asian cohort in Singapore, 1994–2015
      Christina Ong, Marion M Aw, Maria J Liwanag, Seng H Quak, Kong B Phua
      Journal of Digestive Diseases.2018; 19(7): 395.     CrossRef
    • Urbanization and the gut microbiota in health and inflammatory bowel disease
      Tao Zuo, Michael A. Kamm, Jean-Frédéric Colombel, Siew C. Ng
      Nature Reviews Gastroenterology & Hepatology.2018; 15(7): 440.     CrossRef
    • Molecular diagnosis and classification of inflammatory bowel disease
      Hu Zhang, Zhen Zeng, Arjudeb Mukherjee, Bo Shen
      Expert Review of Molecular Diagnostics.2018; 18(10): 867.     CrossRef
    • Characteristics and management of patients with inflammatory bowel disease between a secondary and tertiary hospitals: a propensity score analysis
      Ki Hwan Song, Eun Soo Kim, Yoo Jin Lee, Byung Ik Jang, Kyeong Ok Kim, Sang Gyu Kwak, Hyun Seok Lee
      Intestinal Research.2018; 16(2): 216.     CrossRef
    • Predictors and clinical outcomes of follow‐up loss in patients with inflammatory bowel disease
      Dae Hyung Woo, Kyeong Ok Kim, Min Kyu Kang, Si Hyung Lee, Byung Ik Jang, Tae Nyeun Kim
      Journal of Gastroenterology and Hepatology.2018; 33(11): 1834.     CrossRef
    • Are Truelove and Witts criteria for diagnosing acute severe colitis relevant for the Indian population? A prospective study
      Saransh Jain, Saurabh Kedia, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Peush Sahni, Sujoy Pal, Nihar Ranjan Dash, Govind Makharia, Simon P. L. Travis, Vineet Ahuja
      Intestinal Research.2018; 16(1): 69.     CrossRef
    • Risk factors for inflammatory bowel disease: A prospective multi-center study
      Anjali D. Amarapurkar, Deepak N. Amarapurkar, Pravin Rathi, Prabha Sawant, Nikhil Patel, Praful Kamani, Krishnakant Rawal, Rajiv Baijal, Ameya Sonawane, Nitin Narawane, Samrat Kolekar, Naveen Totla
      Indian Journal of Gastroenterology.2018; 37(3): 189.     CrossRef
    • Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies
      Satoshi Motoya, Mamoru Watanabe, Hyo Jong Kim, Young Ho Kim, Dong Soo Han, Hirotoshi Yuasa, Junichi Tabira, Naoki Isogawa, Shoko Arai, Isao Kawaguchi, Toshifumi Hibi
      Intestinal Research.2018; 16(2): 233.     CrossRef
    • Genomic characterization of colitis-associated colorectal cancer
      Hitoshi Kameyama, Masayuki Nagahashi, Yoshifumi Shimada, Yosuke Tajima, Hiroshi Ichikawa, Masato Nakano, Jun Sakata, Takashi Kobayashi, Sumana Narayanan, Kazuaki Takabe, Toshifumi Wakai
      World Journal of Surgical Oncology.2018;[Epub]     CrossRef
    • Changing treatment paradigms for the management of inflammatory bowel disease
      Jong Pil Im, Byong Duk Ye, You Sun Kim, Joo Sung Kim
      The Korean Journal of Internal Medicine.2018; 33(1): 28.     CrossRef
    • Significant Medical and Surgical Morbidity in Perianal Crohn’s Disease: Results from a Territory-Wide Study
      Wing Yan Mak, Oi Sze Mak, Choon Kin Lee, Whitney Tang, Wai Keung Leung, Marc T L Wong, Alex Shun Fung Sze, Michael Li, Chi Man Leung, Fu Hang Lo, Belsy C Y Lam, Kam Hon Chan, Edwin Hok Shing Shan, Steven Woon Choy Tsang, Aric J Hui, Wai Hung Chow, Francis
      Journal of Crohn's and Colitis.2018;[Epub]     CrossRef
    • Neat1-miRNA204-5p-PI3K-AKT axis as a potential mechanism for photodynamic therapy treated colitis in mice
      Kunpeng Wang, Zijian Zhang, Kai Liu, Xin Yang, Heng Zou, Jiangjiao Zhou, Xiongying Miao, Wei Chen, Li Xiong, Yu Wen
      Photodiagnosis and Photodynamic Therapy.2018; 24: 349.     CrossRef
    • Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study
      Seona Park, Jaeyoung Chun, Kyung-Do Han, Hosim Soh, Kookhwan Choi, Ji Hye Kim, Jooyoung Lee, Changhyun Lee, Jong Pil Im, Joo Sung Kim
      World Journal of Gastroenterology.2018; 24(42): 4798.     CrossRef
    • Genetics of ulcerative colitis: putting into perspective the incremental gains from Indian studies
      Garima Juyal, Ajit Sood, Vandana Midha, B. K. Thelma
      Journal of Genetics.2018; 97(5): 1493.     CrossRef
    • Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study
      Jaeyoung Chun, Jong Pil Im, Ji Won Kim, Kook Lae Lee, Chang Hwan Choi, Hyunsoo Kim, Jae Hee Cheon, Byong Duk Ye, Young-Ho Kim, You Sun Kim, Yoon Tae Jeen, Dong Soo Han, Won Ho Kim, Joo Sung Kim
      Gut and Liver.2018; 12(5): 544.     CrossRef
    • Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn’s disease
      Christina Ong, Poh Ting Lim, Veena Logarajah, Maria Janelle Liwanag, Bi Xia Ang, Yuqin Cher, Fang Kuan Chiou, Ajmal Kader
      BMC Gastroenterology.2018;[Epub]     CrossRef
    • Incidence and clinical outcomes of intestinal Behçet’s disease in Korea, 2011–2014: a nationwide population-based study
      Minkyung Han, Yoon Suk Jung, Won Ho Kim, Jae Hee Cheon, Sohee Park
      Journal of Gastroenterology.2017; 52(8): 920.     CrossRef
    • Tuberculosis screening using IGRA and chest computed tomography in patients with inflammatory bowel disease: A retrospective study
      Dong Juan Song, Jin Lu Tong, Jiang Chen Peng, Chen Wen Cai, Xi Tao Xu, Ming Ming Zhu, Zhi Hua Ran, Qing Zheng
      Journal of Digestive Diseases.2017; 18(1): 23.     CrossRef
    • Role of MiRNAs in Inflammatory Bowel Disease
      Bo Cao, Xin Zhou, Jiaojiao Ma, Wei Zhou, Wanli Yang, Daiming Fan, Liu Hong
      Digestive Diseases and Sciences.2017; 62(6): 1426.     CrossRef
    • Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases
      Jean-Frederic Colombel, Neeraj Narula, Laurent Peyrin-Biroulet
      Gastroenterology.2017; 152(2): 351.     CrossRef
    • Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
      Jong Pil Im
      Intestinal Research.2017; 15(2): 147.     CrossRef
    • Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
      Shu-Chen Wei, Ting-An Chang, Te-Hsin Chao, Jinn-Shiun Chen, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tien-Yu Huang, Tzu-Chi Hsu, Chun-Chi Lin, Hung-Hsin Lin, Jen-Kou Lin, Wei-Chen Lin, Yen-Hsuan Ni, Ming-Jium Shieh, I-Lun Shih, Chi
      Intestinal Research.2017; 15(3): 285.     CrossRef
    • Is there a potential role of fecal microbiota transplantation in the treatment of inflammatory bowel disease?
      Chang Soo Eun
      Intestinal Research.2017; 15(2): 145.     CrossRef
    • Effect of Immunomodulators and Biologic Agents on Malignancy in Patients with Inflammatory Bowel Disease
      Jee Hyun Kim, Ji Won Kim
      Korean Journal of Gastroenterology.2017; 70(4): 162.     CrossRef
    • Second Korean guidelines for the management of Crohn's disease
      Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee
      Intestinal Research.2017; 15(1): 38.     CrossRef
    • Inflammatory bowel disease is no longer a risk factor of viral hepatitis infection in Asia
      Eun Soo Kim
      Intestinal Research.2017; 15(1): 5.     CrossRef
    • Tofacitinib for Ulcerative Colitis — A Promising Step Forward
      Sonia Friedman
      New England Journal of Medicine.2017; 376(18): 1792.     CrossRef
    • Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease: a subpopulation analysis of phase 3 induction and maintenance studies
      Toshifumi Hibi, Yuya Imai, Yoko Murata, Nobuko Matsushima, Richuan Zheng, Christopher Gasink
      Intestinal Research.2017; 15(4): 475.     CrossRef
    • Clinical course of ulcerative colitis patients who develop acute pancreatitis
      Jong Wook Kim, Sung Wook Hwang, Sang Hyoung Park, Tae Jun Song, Myung-Hwan Kim, Ho-Su Lee, Byong Duk Ye, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang
      World Journal of Gastroenterology.2017; 23(19): 3505.     CrossRef
    • Second Korean Guidelines for the Management of Crohn's Disease
      Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee
      The Korean Journal of Gastroenterology.2017; 69(1): 29.     CrossRef
    • Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
      Eun Hye Oh, Dae-Hyun Ko, Hyungil Seo, Kiju Chang, Gwang-Un Kim, Eun Mi Song, Myeongsook Seo, Ho-Su Lee, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park
      World Journal of Gastroenterology.2017; 23(8): 1489.     CrossRef
    • An update on diagnostic and prognostic biomarkers in inflammatory bowel disease
      Andrew S. Day, Steven T. Leach, Daniel A. Lemberg
      Expert Review of Molecular Diagnostics.2017; 17(9): 835.     CrossRef
    • Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis
      Suraj Kumar, Sawan Bopanna, Saurabh Kedia, Pratap Mouli, Rajan Dhingra, Rajesh Padhan, Mikashmi Kohli, Jigyasa Chaubey, Rohini Sharma, Prasenjit Das, S Dattagupta, Govind Makharia, SK Sharma, Vineet Ahuja
      Intestinal Research.2017; 15(2): 187.     CrossRef
    • Second Korean Guideline for the Management of Ulcerative Colitis
      Chang Hwan Choi, Won Moon, You Sun Kim, Eun Soo Kim, Bo-In Lee, Yunho Jung, Yong Sik Yoon, Heeyoung Lee, Dong Il Park, Dong Soo Han
      The Korean Journal of Gastroenterology.2017; 69(1): 1.     CrossRef
    • Factors associated with pregnancy-related knowledge in women of reproductive age with inflammatory bowel disease
      Ko Eun Lee, Sung-Ae Jung, Hyuk Yoon, Sang Hyoung Park, Chang Mo Moon, Eun Soo Kim, Seong-Eun Kim, Suk-Kyun Yang
      Scandinavian Journal of Gastroenterology.2017; 52(8): 833.     CrossRef
    • Malignant Melanoma of the Anus Found during Routine Colonoscopy in Ulcerative Colitis
      Kwang Il Seo, Won Moon, Sung Eun Kim, Moo In Park, Seun Ja Park
      The Korean Journal of Gastroenterology.2017; 69(6): 368.     CrossRef
    • Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner
      Changhyun Lee, Byeong Gwan Kim, Jee Hyun Kim, Jaeyoung Chun, Jong Pil Im, Joo Sung Kim
      International Immunopharmacology.2017; 51: 47.     CrossRef
    • Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011–2014: A Nationwide Population-Based Study
      Yoon Suk Jung, Minkyung Han, Won Ho Kim, Sohee Park, Jae Hee Cheon
      Digestive Diseases and Sciences.2017; 62(8): 2102.     CrossRef
    • Cancer Risk in the Early Stages of Inflammatory Bowel Disease in Korean Patients: A Nationwide Population-based Study
      Yoon Suk Jung, Minkyung Han, Sohee Park, Won Ho Kim, Jae Hee Cheon
      Journal of Crohn's and Colitis.2017; 11(8): 954.     CrossRef
    • Second Korean guidelines for the management of ulcerative colitis
      Chang Hwan Choi, Won Moon, You Sun Kim, Eun Soo Kim, Bo-In Lee, Yunho Jung, Yong Sik Yoon, Heeyoung Lee, Dong Il Park, Dong Soo Han
      Intestinal Research.2017; 15(1): 7.     CrossRef
    • Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn’s disease with poor prognostic factors
      Eun Hye Oh, Kyunghwan Oh, Minkyu Han, Hyungil Seo, Kiju Chang, Sun-Ho Lee, Gwang-Un Kim, Eun Mi Song, Myeongsook Seo, Ho-Su Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
      PLOS ONE.2017; 12(5): e0177479.     CrossRef
    • Development of a Novel Predictive Model for the Clinical Course of Crohnʼs Disease
      Yehyun Park, Jae Hee Cheon, Yi Lang Park, Byong Duk Ye, You Sun Kim, Dong Soo Han, Joo Sung Kim, Sung Noh Hong, Young Ho Kim, Seong Ran Jeon, Won Ho Kim
      Inflammatory Bowel Diseases.2017; 23(7): 1071.     CrossRef
    • RNA-seq Reveals Transcriptomic Differences in Inflamed and Noninflamed Intestinal Mucosa of Crohnʼs Disease Patients Compared with Normal Mucosa of Healthy Controls
      Sung Noh Hong, Je-Gun Joung, Joon Seol Bae, Chan Soo Lee, Ja Seol Koo, Soo Jung Park, Jong Pil Im, You Sun Kim, Ji Won Kim, Woong Yang Park, Young-Ho Kim
      Inflammatory Bowel Diseases.2017; 23(7): 1098.     CrossRef
    • The Phase 3 Trials of Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
      Sang Hyoung Park
      The Korean Journal of Gastroenterology.2017; 69(1): 90.     CrossRef
    • Role of Smoking as a Risk Factor in East Asian Patients with Crohn's Disease
      Sung Chul Park, Yoon Tae Jeen
      Gut and Liver.2017; 11(1): 7.     CrossRef
    • Disability due to Inflammatory Bowel Disease Is Correlated with Drug Compliance, Disease Activity, and Quality of Life
      Jin Young Yoon, Jeong Eun Shin, Sang Hyoung Park, Dong Il Park, Jae Myung Cha
      Gut and Liver.2017; 11(3): 370.     CrossRef
    • Practice patterns and clinical significance of use of capsule endoscopy in suspected and established Crohn's disease
      Yonghyun Kim, Seong Ran Jeon, Sang Myung Choi, Hyun Gun Kim, Tae Hee Lee, Jun-Hyung Cho, Yunho Jung, Wan Jung Kim, Bong Min Ko, Jin-Oh Kim, Joon Sung Lee, Moon Sung Lee
      Intestinal Research.2017; 15(4): 467.     CrossRef
    • Epidemiology, Natural History, and Risk Stratification of Crohn's Disease
      Satimai Aniwan, Sang Hyoung Park, Edward V. Loftus
      Gastroenterology Clinics of North America.2017; 46(3): 463.     CrossRef
    • Comparison of 4-L Polyethylene Glycol and 2-L Polyethylene Glycol Plus Ascorbic Acid in Patients with Inactive Ulcerative Colitis
      Eun Soo Kim, Kyeong Ok Kim, Byung Ik Jang, Eun Young Kim, Yoo Jin Lee, Hyun Seok Lee, Seong Woo Jeon, Hyun Jin Kim, Sung Kook Kim
      Digestive Diseases and Sciences.2017; 62(9): 2489.     CrossRef
    • Depressive Symptoms and Quality of Life in the Patients of Inflammatory Bowel Disease
      Jung Won Lee
      Gut and Liver.2017; 11(4): 449.     CrossRef
    • Pivot to Asia: inflammatory bowel disease burden
      Prashant Singh, Ashwin Ananthakrishnan, Vineet Ahuja
      Intestinal Research.2017; 15(1): 138.     CrossRef
    • Temporal Trend of Pediatric Inflammatory Bowel Disease
      Takashi Ishige, Takeshi Tomomasa, Reiko Hatori, Maiko Tatsuki, Yoshiko Igarashi, Kazuhiko Sekine, Hirokazu Arakawa
      Journal of Pediatric Gastroenterology and Nutrition.2017;[Epub]     CrossRef
    • Disability Index as a New Outcome Measure in Patients with Inflammatory Bowel Disease
      Hyun Ho Choi, Young-Seok Cho
      Gut and Liver.2017; 11(3): 319.     CrossRef
    • X Chromosome-wide Association Study Identifies a Susceptibility Locus for Inflammatory Bowel Disease in Koreans
      Ho-Su Lee, Hyunjung Oh, Suk-Kyun Yang, Jiwon Baek, Seulgi Jung, Myunghee Hong, Kyung Mo Kim, Hyoung Doo Shin, Kyung-Jo Kim, Sang Hyoung Park, Byong Duk Ye, Buhm Han, Kyuyoung Song
      Journal of Crohn's and Colitis.2017; 11(7): 820.     CrossRef
    • Asians Have More Perianal Crohn Disease and Ocular Manifestations Compared with White Americans
      Bharati Kochar, Edward L. Barnes, Hans H. Herfarth, Christopher F. Martin, Ashwin N. Ananthakrishnan, Dermot McGovern, Millie D. Long, Robert S. Sandler
      Inflammatory Intestinal Diseases.2017; 2(3): 147.     CrossRef
    • NF-kappa B activation correlates with disease phenotype in Crohn’s disease
      Yoo Min Han, Jaemoon Koh, Ji Won Kim, Changhyun Lee, Seong-Joon Koh, ByeongGwan Kim, Kook Lae Lee, Jong Pil Im, Joo Sung Kim, Gernot Sellge
      PLOS ONE.2017; 12(7): e0182071.     CrossRef
    • Irritable Inflammatory Bowel Syndrome as a Distinct Disease Entity
      Jung Hwan Oh
      Journal of Neurogastroenterology and Motility.2016; 22(4): 545.     CrossRef
    • Risk factors for developing colorectal cancer in Japanese patients with ulcerative colitis: a retrospective observational study—CAPITAL (Cohort and Practice for IBD total management in Kyoto-Shiga Links) study I
      Takuya Yoshino, Hiroshi Nakase, Tomohisa Takagi, Shigeki Bamba, Yusuke Okuyama, Takuji Kawamura, Teruki Oki, Hirozumi Obata, Chiharu Kawanami, Shinji Katsushima, Toshihiro Kusaka, Tomoyuki Tsujikawa, Yuji Naito, Akira Andoh, Takafumi Kogawa
      BMJ Open Gastroenterology.2016; 3(1): e000122.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Changing epidemiological trends of inflammatory bowel disease in Asia
      Intest Res. 2016;14(2):111-119.   Published online April 27, 2016
      DOI: https://doi.org/10.5217/ir.2016.14.2.111
      Close
    • XML DownloadXML Download
    Related articles
    Changing epidemiological trends of inflammatory bowel disease in Asia
    Changing epidemiological trends of inflammatory bowel disease in Asia

    Incidence and Prevalence Rates of IBD in Various Asian Countries

    CountryPeriodIncidence Rate
    (per 100,000 persons)    		UC/CDPrevalence Rate
    (per 100,000 persons)
    UCCDUCCD
    Korea1986−1990170.34a0.05a6.8--
    1991−1995170.87a0.22a3.9--
    1996−2000171.74a0.52a3.37.60-
    2001−2005173.08a1.34a2.330.9011.20
    2006−2012184.603.201.4--
    Japan1965190.080.018.05.500.88
    1991121.950.513.818.105.90
    200513---63.60b21.10b
    201314---121.9030.10
    Mainland China (Guangzhou)2011−201242.221.221.8--
    Mainland China (Wuhan)2010−201161.590.562.8--
    Mainland China (Daqing)2012−201371.640.1312.6--
    Mainland China (Chengdu)2011−201240.430.143.0--
    Mainland China (Xian)2011−201240.420.076.0--
    Hong Kong1990−1992200.800.402.0--
    1999−2001201.201.001.2--
    2011−201241.661.311.2--
    Macau2011−201241.000.601.7--
    Sri Lanka2011−201240.950.591.6--
    Taiwan2000−2010210.840.213.9--
    Singapore2011−201240.610.401.5--
    Malaysia2011−20134,80.590.242.56.672.17
    Indonesia2011−201240.550.331.7--
    Thailand (Chiangmai)2011−201240.360.301.2--
    Thailand (Bangkok)2011−201240.350.281.3--
    India (Punjab)1999−200096.02--44.30-

    aAge and sex-standardized rates.

    bAge standardized rate.
    Table 1 Incidence and Prevalence Rates of IBD in Various Asian Countries

    aAge and sex-standardized rates.

    bAge standardized rate.

    Table 1

    Intest Res : Intestinal Research
    © Korean Association for the Study of Intestinal Diseases.
    Close layer
    TOP